SEARCH

Search Details

Morita Shinya

Hokkaido University Hospital Division of Neural and Sensory OrgansLecturer

Researcher basic information

■ Degree
  • 博士, 北海道大学
■ URL
researchmap URLホームページURL■ Various IDs
J-Global ID■ Research Keywords and Fields
Research Field
  • Life Science, Otorhinolaryngology
■ Educational Organization

Career

■ Career
Career
  • Aug. 2025 - Present
    Hokkaido University, 大学病院, 講師

Research activity information

■ Papers
  • Safe administration of botulinum neurotoxin type A for facial nerve palsy sequelae in a patient with myasthenia gravis.
    Keishi Fujiwara; Shinya Morita; Kimiko Hoshino; Hideaki Takeda; Kento Komatsuda; Kosuke Ueda; Yuji Nakamaru; Akihiro Homma
    Auris, nasus, larynx, 11 Aug. 2026, [International Magazine]
    English, Scientific journal, Botulinum neurotoxin type A (BoNT-A) is an effective treatment for facial nerve palsy sequelae; however, its use in patients with myasthenia gravis (MG) is generally contraindicated due to the risk of exacerbating neuromuscular blockade. We report a female in her 40 s with a 10-year history of generalized, seronegative MG who presented with facial tightness and mild synkinesis due to facial nerve palsy sequelae. As BoNT-A is contraindicated for MG patients in Japan, we obtained approval for off-label use from the Division of Patient Safety Management in our hospital. Under a predefined risk management protocol established to meet the approval conditions, a reduced dose of BoNT-A (3 units) was administered to the affected side. Safety measures included pre- and post-injection vital sign monitoring, frequent follow-ups, and advance information sharing with the on-call otolaryngologists. The patient experienced no respiratory failure or systemic MG exacerbation. At 2 months post-injection, objective grading (Sunnybrook Facial Grading System) and patient-reported outcomes (Facial Clinimetric Evaluation scale) demonstrated sustained improvement, particularly in facial tightness and psychological well-being. This case supports the cautious use of BoNT-A for facial palsy sequelae in patients with underlying MG when a predefined risk management protocol and low-dose strategy are employed.
  • Eustachian Tube Enhancement Directly Reflects Disease Activity in ANCA-Associated Otitis Media.
    Taro Fujikawa; Nobuhiro Hakuba; Toru Miwa; Jun Oyama; Emi Yamaga; Natsuka Umezawa; Shinya Morita; Yoshiyuki Kawashima; Taku Ito; Kaori Mohri; Takeshi Tsutsumi
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 47, 5, 744, 750, 01 Jun. 2026, [International Magazine]
    English, Scientific journal, OBJECTIVE: Otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) is associated with Eustachian tube (ET) involvement. To date, the clinical feasibility of using contrast-enhanced magnetic resonance imaging (CE-MRI) to assess ET enhancement in OMAAV management remains unclear. Therefore, we investigated whether ET enhancement on CE-MRI reflects disease activity in patients with ANCA-associated vasculitis (AAV)/OMAAV. STUDY DESIGN: Prospective cohort with within-patient comparisons. SETTING: Tertiary referral center. PATIENTS: Eight patients with AAV (12 OMAAVs) and 8 with otitis media with effusion (OME) as controls. INTERVENTION: All patients underwent 3.0-Tesla fat-suppressed CE-MRI with <1 mm slice thickness at disease onset and also in remission for patients with OMAAV. Myeloperoxidase-deoxyribonucleic acid (MPO-DNA) complex levels in middle ear fluid samples were measured to confirm OMAAV diagnosis. MAIN OUTCOME MEASURE: MRI signal intensities in each anatomic ET segment, audiometric results, and biomarker levels, compared with disease activity. RESULTS: In active OMAAV, ETs showed significant contrast enhancement on the affected side in all patients, even those with prior oral steroid use. ET enhancement was distributed in at least 2 continuous segments centered on the isthmus (12 OMAAVs, 100%), and enhancement was remarkably diminished during remission. ET enhancement positivity was closely associated with higher levels of ANCA and MPO-DNA complex ( P <0.001). The diagnostic performance of ET enhancement was 100%/87.5% (sensitivity/specificity) for evaluating OMAAV disease activity and 100%/91.7% (sensitivity/specificity) for differentiating active OMAAV from non-OMAAV conditions. CONCLUSION: ET enhancement on high-resolution CE-MRI provides radiologic evidence of localized vasculitic inflammation in patients with active OMAAV.
  • Psychological outcomes of botulinum toxin treatment for facial nerve palsy sequelae: A retrospective analysis of anxiety and depression.
    Keishi Fujiwara; Shinya Morita; Hiroko Yanagi; Kimiko Hoshino; Hideaki Takeda; Kento Komatsuda; Yuji Nakamaru; Yasushi Furuta; Akihiro Homma
    Auris, nasus, larynx, 53, 3, 435, 440, Jun. 2026, [International Magazine]
    English, Scientific journal, OBJECTIVES: To evaluate the changes in anxiety and depressive symptoms following onabotulinumtoxinA (BoNT-A) treatment in patients with facial nerve palsy (FNP) sequelae. METHODS: This retrospective study included 20 patients with FNP sequelae treated with BoNT-A. Anxiety, depression, and quality of life (QOL) were assessed using the State-Trait Anxiety Inventory (STAI), Self-Rating Depression Scale (SDS), and Facial Clinimetric Evaluation (FaCE) scale at baseline and 1, 3, and 6 months post-injection. To address pharmacodynamic variability, the best score at 1 or 3 months was defined as the "post-treatment peak." Correlations between clinical factors (age, disease duration, and facial grading scores) and therapeutic outcomes were analyzed using Spearman's rank correlation. RESULTS: At the post-treatment peak, significant improvements were observed in FaCE (p = 0.0029), SDS (p = 0.0032), and STAI-State (p = 0.0014) scores compared to baseline. However, these improvements returned to baseline levels at 6 months. STAI-Trait scores remained stable throughout the study. Older age was significantly associated with limited improvement in depressive symptoms (r = 0.59, p = 0.0061), and severe baseline synkinesis was negatively correlated with the magnitude of improvement in facial-related QOL (r = -0.47, p = 0.038). CONCLUSIONS: BoNT-A treatment effectively but transiently improves physical symptoms and secondary psychological distress, including reactive anxiety and depression. Older age and severe synkinesis may limit therapeutic benefits, highlighting the importance of comprehensive management and maintenance therapy to sustain mental well-being.
  • Hearing characteristics of Branchio-oto-renal syndrome in Japan
    Shin-ichi Goto; Akira Sasaki; Shin-ya Nishio; Shin-ya Morita; Noriko Ogasawara; Yumiko Kobayashi; Akiko Amano; Chikako Shinkawa; Kiyoshi Oda; Tetsuro Wada; Tetsuo Ikezono; Han Matsuda; Michiro Fujisaka; Kyoko Nagai; Hidekane Yoshimura; Akinori Kashio; Nobuhiro Nishiyama; Taku Ito; Shori Tajima; Shin-ichiro Oka; Kimitaka Kaga; Hidehiko Takeda; Marina Kobayashi; Hajime Sano; Yasuhiro Arai; Hiroshi Nakanishi; Hiromi Koizumi; Natsuko Obara; Tadao Yoshida; Tomoko Esaki; Kazuhiko Takeuchi; Hiroshi Yamazaki; Rie Horie; Yumi Ohta; Chihiro Morimoto; Natsumi Uehara; Yasushi Naito; Yukihide Maeda; Takashi Ishino; Kentaro Egusa; Kazuma Sugahara; Masato Teraoka; Eiji Kondo; Nana Tsuchihashi; Chiharu Kihara; Yukihiko Kanda; Takeshi Nakamura; Ikuyo Miyanohara; Shunsuke Kondo; Shin-ichi Usami
    ACTA OTO-LARYNGOLOGICA, 17 Mar. 2026
    English, Scientific journal
  • Eosinophil Extracellular Trap Remnants as Potential Biomarkers for the Diagnosis and Activity Assessment of Otitis Media Associated With Eosinophilic Granulomatosis With Polyangiitis and Eosinophilic Otitis Media.
    Shinya Morita; Yoshihiko Esu; Yuji Nakamaru; Atsushi Fukuda; Keishi Fujiwara; Masanobu Suzuki; Kimiko Hoshino; Kento Komatsuda; Aya Honma; Akira Nakazono; Naohiro Yoshida; Akihiro Homma
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 47, 2, e331-e338, 01 Feb. 2026, [Peer-reviewed], [International Magazine]
    English, Scientific journal, OBJECTIVE: This study hypothesized that the expression levels of eosinophil extracellular traps (EETs) in middle ear lavage fluid and serum would correlate with various clinical parameters in otitis media associated with eosinophilic granulomatosis with polyangiitis (EGPA) and eosinophilic otitis media (EOM). The aim of this study was to evaluate the potential utility of EETs as diagnostic and monitoring tools for assessing disease activity and therapeutic response. STUDY DESIGN: Exploratory research. SETTING: Two tertiary referral centers. PATIENTS: EGPA and EOM patients were eligible for inclusion. Patients with chronic otitis media (COM) were examined as controls. INTERVENTION: The middle ear lavage and blood samples were obtained from patients with EGPA, EOM, and COM. MAIN OUTCOME MEASURES: The levels of cell-free deoxyribonucleic acid (DNA), citrullinated-histone H3 (cit-H3)-DNA complex, and eosinophil peroxidase (EPO)-DNA complex as EET remnants were quantified using an enzyme-linked immunosorbent assay. RESULTS: Patients with EGPA and EOM showed significantly higher levels of EET remnants in the middle ear lavage compared with controls. In patients with EGPA and EOM, the levels of EET remnants in the middle ear lavage at post-treatment were significantly lower compared with those at pretreatment. Furthermore, the levels of EET remnants in the middle ear lavage were positively correlated with Lund-Mackay scores and temporal bone CT scores. It is noteworthy that EET remnants in the serum of patients with EGPA were found to be elevated and were positively correlated with peripheral blood eosinophil fraction and serum immunoglobulin E levels. CONCLUSIONS: These preliminary findings suggest that EET remnants in the middle ear lavage may be potentially useful as biomarkers for the diagnosis and disease activity of otologic lesions in EGPA and EOM. It seems acceptable to measure the levels of EET remnants using blood samples in patients with EGPA., 50934544
  • VEXAS syndrome with cochleovestibular involvement.
    Keishi Fujiwara; Shinya Morita; Kimiko Hoshino; Hideaki Takeda; Kento Komatsuda; Kaoru Kahata; Yuji Nakamaru; Akihiro Homma
    Auris, nasus, larynx, 53, 1, 70, 75, 18 Dec. 2025, [International Magazine]
    English, Scientific journal, We report a case of VEXAS syndrome in a 71-year-old man presenting with auricular chondritis, scleritis, hearing loss, and vestibular dysfunction. Although the clinical picture initially suggested relapsing polychondritis, hematologic findings and UBA1 variant confirmed VEXAS syndrome. Comprehensive audiovestibular testing revealed bilateral sensorineural hearing loss and global vestibular impairment. Steroid therapy led to partial improvement. This case highlights the potential for inner ear involvement in VEXAS syndrome, underscoring the importance of systematic audiovestibular evaluation and clinical awareness to differentiate it from similar conditions such as relapsing polychondritis.
  • The Therapeutic Effects of Systemic Corticosteroid and Immunosuppressants for New-Onset Cases and Mepolizumab for Recurrent Cases of Otitis Media Associated With Eosinophilic Granulomatosis with Polyangiitis.
    Shinya Morita; Atsushi Fukuda; Kimiko Hoshino; Yuji Nakamaru; Keishi Fujiwara; Masanobu Suzuki; Aya Honma; Akira Nakazono; Akihiro Homma
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 18 Jun. 2025, [Peer-reviewed], [International Magazine]
    English, Scientific journal, OBJECTIVE: The aims of this study were to evaluate the otologic features and outcomes of otitis media associated with eosinophilic granulomatosis with polyangiitis (EGPA) and validate the current treatment strategies, including systemic corticosteroid (CS) and immunosuppressants for new-onset cases and therapeutic targeting of interleukin (IL)-5 for recurrent cases. STUDY DESIGN: Retrospective case series. SETTING: Tertiary referral center. PATIENTS: Patients with otitis media associated with EGPA were eligible for inclusion. INTERVENTION: Systemic CS alone or a combination of systemic CS and intravenous cyclophosphamide (IVCY) was performed as induction therapy. Maintenance therapy with oral CS and immunosuppressant, such as rituximab, methotrexate, or azathioprine, was administered. Treatment with mepolizumab was performed at the time of relapse of major organ involvement in EGPA, exacerbation of asthma, and/or recurrence of ear, nose, and throat symptoms after remission induction. MAIN OUTCOME MEASURES: Air- and bone-conduction pure-tone thresholds, overall survival rate, EGPA relapse rate, and otitis media recurrence rate. RESULTS: Systemic CS-based induction therapy achieved remission in all patients with EGPA. In both the CS + IVCY and CS-alone groups, hearing thresholds in the remission and/or resolution phase were significantly better than those at initial presentation at all frequencies (p < 0.01). The 5-year estimated relapse rate of major organ involvement was 29.2%, and the 5-year estimated recurrence rate of otitis media was 43.6%. All cases of recurrent otitis media treated with mepolizumab achieved improvement in otologic symptoms and subsequent reduction in maintenance CS dose. However, half of ears with recurrent otitis media showed repeated secretion and cessation of middle ear discharge and required additional topical CS treatment during mepolizumab administration. CONCLUSIONS: Immunosuppressive treatment affords a good response to systemic manifestations as well as otitis media associated with EGPA. Meanwhile, a significant proportion of patients experienced exacerbation of otitis media during maintenance therapy. Mepolizumab might be the treatment of choice for recurrent cases.
  • Post-operative vestibular function outcomes evaluated by video Head Impulse Test in patients with non-vestibular schwannoma cerebellopontine angle tumors.
    Keishi Fujiwara; Shinya Morita; Hiroaki Motegi; Shigeru Yamaguchi; Yukitomo Ishi; Kimiko Hoshino; Atsushi Fukuda; Hideaki Takeda; Yuji Nakamaru; Miki Fujimura; Akihiro Homma
    Auris, nasus, larynx, 52, 1, 50, 58, Feb. 2025, [International Magazine]
    English, Scientific journal, OBJECTIVES: To evaluate post-operative semicircular canal function in patients with non-vestibular schwannoma (VS) cerebellopontine angle (CPA) tumors by video Head Impulse Test (vHIT). METHODS: Fourteen patients with non-VS CPA tumors who underwent surgery. The gain in vestibulo-ocular reflex (VOR) was examined pre- and post-operatively for the semicircular canals in patients with non-VS CPA tumors. RESULTS: Ten of 14 patients showed semicircular canal dysfunction in one or more of the semicircular canals pre-operatively and VOR gain was significantly correlated with hearing function. Two patients showed improvement in one or more semicircular canals at 1 month after surgery compared to the pre-operative results. Significant improvements in VOR gain were observed when comparing VOR gain at 1 month and 6 months after surgery. CONCLUSIONS: Detailed evaluation of semicircular canal function was achieved by using vHIT in patients with non-VS CPA tumors. The good prognosis for vestibular function as evaluated by vHIT post-operatively was confirmed in patients with non-VS CPA tumors when compared to those in patients with VS. As improvement may occur post-operatively, surgical approaches that preserve the vestibular nerves and semicircular canals should be chosen for patients with non-VS CPA tumors, regardless of preoperative vestibular function. Even if vestibular function deteriorates immediately after surgery, it may improve over time if the nerve is preserved.
  • The Heterozygous p.A684V Variant in the WFS1 Gene Is a Mutational Hotspot Causing a Severe Hearing Loss Phenotype.
    Shintaro Otsuka; Chihiro Morimoto; Shin-Ya Nishio; Shinya Morita; Daisuke Kikuchi; Masahiro Takahashi; Kozo Kumakawa; Yasuhiro Arai; Hajime Sano; Hidekane Yoshimura; Norio Yamamoto; Shunsuke Kondo; Mari Hasegawa; Tomo Nishi; Tadashi Kitahara; Shin-Ichi Usami
    Genes, 16, 1, 06 Jan. 2025, [International Magazine]
    English, Scientific journal, BACKGROUND/OBJECTIVES: A heterozygous mutation in the WFS1 gene is responsible for autosomal dominant non-syndromic hearing loss (DFNA6/14/38) and Wolfram-like syndrome, which is characterized by bilateral sensorineural hearing loss with optic atrophy and/or diabetes mellitus. However, detailed clinical features for the patients with the heterozygous p.A684V variant remain unknown. METHODS: We report the clinical details of 14 cases with a heterozygous p.A684V variant in the WFS1 gene identified from target resequencing analysis of 63 previously reported deafness genes by next-generation sequencing of 15,684 hearing loss patients (mean age 27.5 ± 23.1 years old, 6574 male, 8612 female and 498 for whom information was unavailable). RESULTS: Among the 14 patients from 13 families with the p.A684V variant, nine were sporadic cases. In addition, we confirmed de novo occurrence of this variant in seven families. This result strongly supports the notion that this variant was located on a mutational hotspot. When comparing previously reported cases of autosomal dominant WFS1 gene-associated hearing loss, most of the patients in this study showed severe-to-profound bilateral sensorineural hearing loss (genotype-phenotype correlation). Two patients had optic atrophy, while the others did not have any other complications. CONCLUSIONS: The identified heterozygous p.A684V variant appears to be a hotspot mutation and likely to cause severe-to-profound hearing loss in early childhood. Cochlear implantation is considered favorable in cases of hearing impairment due to this variant.
  • Evaluation of Semicircular Canal Function in Relapsing Polychondritis Patients With Dizziness and Sensorineural Hearing Loss Using Video Head Impulse Test.
    Kimiko Hoshino; Keishi Fujiwara; Shinya Morita; Atsushi Fukuda; Hideaki Takeda; Yuji Nakamaru; Akihiro Homma
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 45, 9, 1045, 1050, 01 Oct. 2024, [International Magazine]
    English, Scientific journal, OBJECTIVE: To evaluate semicircular canal function using video head impulse test (vHIT) in relapsing polychondritis (RP) patients presenting with dizziness and sensorineural hearing loss. STUDY DESIGN: Retrospective case review. SETTING: Tertiary referral center. PATIENTS: Three patients with RP underwent vHIT and hearing tests. INTERVENTION: Diagnostic. MAIN OUTCOME MEASURES: The gain in vestibulo-ocular reflex (VOR) and the presence of catch-up saccade were examined, and the correlation between semicircular canal dysfunction and hearing loss was investigated. RESULTS: Of the six ears, five exhibited semicircular canal dysfunction. Among these, one ear showed dysfunction in two semicircular canals, while the remaining four ears demonstrated dysfunction in all three semicircular canals. Sensorineural hearing loss, ranging from moderate to profound, was detected by pure-tone audiometry in all six ears. Furthermore, a significant correlation was observed between VOR gain in the horizontal semicircular canal (HSC) and hearing level. CONCLUSIONS: This study demonstrated semicircular canal dysfunction in RP patients presenting with dizziness and hearing loss using vHIT. Moreover, a significant correlation was found between HSC dysfunction and the severity of hearing loss. While inner ear involvement is a key clinical symptom included in the diagnostic criteria for RP, there have been few reports evaluating vestibular dysfunction, and this is the first report on the evaluation of several cases using vHIT. Accurate assessment of vestibular function by vHIT may facilitate early diagnosis and intervention in RP, potentially improving patient outcomes.
  • Evaluation of Semicircular Canal Function in Relapsing Polychondritis Patients with Dizziness and Sensorineural Hearing Loss Using Video Head Impulse Test.
    Kimiko Hoshino; Keishi Fujiwara; Shinya Morita; Atsushi Fukuda; Hideaki Takeda; Yuji Nakamaru; Akihiro Homma
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 26 Aug. 2024, [International Magazine]
    English, Scientific journal, OBJECTIVE: To evaluate semicircular canal function using video head impulse test (vHIT) in relapsing polychondritis (RP) patients presenting with dizziness and sensorineural hearing loss. STUDY DESIGN: Retrospective case review. SETTING: Tertiary referral center. PATIENTS: Three patients with RP underwent vHIT and hearing tests. INTERVENTION: Diagnostic. MAIN OUTCOME MEASURES: The gain in vestibulo-ocular reflex (VOR) and the presence of catch-up saccade were examined, and the correlation between semicircular canal dysfunction and hearing loss was investigated. RESULTS: Of the six ears, five exhibited semicircular canal dysfunction. Among these, one ear showed dysfunction in two semicircular canals, while the remaining four ears demonstrated dysfunction in all three semicircular canals. Sensorineural hearing loss, ranging from moderate to profound, was detected by pure-tone audiometry in all six ears. Furthermore, a significant correlation was observed between VOR gain in the horizontal semicircular canal (HSC) and hearing level. CONCLUSIONS: This study demonstrated semicircular canal dysfunction in RP patients presenting with dizziness and hearing loss using vHIT. Moreover, a significant correlation was found between HSC dysfunction and the severity of hearing loss. While inner ear involvement is a key clinical symptom included in the diagnostic criteria for RP, there have been few reports evaluating vestibular dysfunction, and this is the first report on the evaluation of several cases using vHIT. Accurate assessment of vestibular function by vHIT may facilitate early diagnosis and intervention in RP, potentially improving patient outcomes.
  • Clinical practice guidelines for the diagnosis and management of acute sensorineural hearing loss.
    Ryosuke Kitoh; Shin-Ya Nishio; Hiroaki Sato; Tetsuo Ikezono; Shinya Morita; Tetsuro Wada; Shin-Ichi Usami
    Auris, nasus, larynx, 51, 4, 811, 821, Aug. 2024, [International Magazine]
    English, Scientific journal, OBJECTIVE: Acute sensorineural hearing loss represents a spectrum of conditions characterized by sudden onset hearing loss. The "Clinical Practice Guidelines for the Diagnosis and Management of Acute Sensorineural Hearing Loss" were issued as the first clinical practice guidelines in Japan outlining the standard diagnosis and treatment. The purpose of this article is to strengthen the guidelines by adding the scientific evidence including a systematic review of the latest publications, and to widely introduce the current treatment options based on the scientific evidence. METHODS: The clinical practice guidelines were completed by 1) retrospective data analysis (using nationwide survey data), 2) systematic literature review, and 3) selected clinical questions (CQs). Additional systematic review of each disease was performed to strengthen the scientific evidence of the diagnosis and treatment in the guidelines. RESULTS: Based on the nationwide survey results and the systematic literature review summary, the standard diagnosis flowchart and treatment options, including the CQs and recommendations, were determined. CONCLUSION: The guidelines present a summary of the standard approaches for the diagnosis and treatment of acute sensorineural hearing loss. We hope that these guidelines will be used in medical practice and that they will initiate further research.
  • Clinical practice guidelines for the diagnosis and management of acute sensorineural hearing loss
    Ryosuke Kitoh; Shin-ya Nishio; Hiroaki Sato; Tetsuo Ikezono; Shinya Morita; Tetsuro Wada; Shin-ichi Usami
    Auris Nasus Larynx, 51, 4, 811, 821, Elsevier BV, Aug. 2024
    Scientific journal
  • A Case of Cochlear Implantation in a Deaf Patient With Eosinophilic Otitis Media in Whom Post-implantation Hearing Threshold Improved After Introduction of Dupilumab.
    Atsushi Fukuda; Kimiko Hoshino; Shinya Morita; Keishi Fujiwara; Akihiro Homma
    Cureus, 16, 7, e65059, Jul. 2024, [International Magazine]
    English, Scientific journal, Eosinophilic otitis media (EOM) is a rare, intractable, and chronic form of otitis media. The associated hearing loss often progresses to deafness, necessitating cochlear implantation (CI). EOM is associated with type 2 inflammatory conditions such as asthma and chronic rhinosinusitis with nasal polyps (CRSwNP). Dupilumab, a monoclonal antibody targeting the IL4Rα subunit, has shown efficacy in mitigating type 2 inflammatory diseases, including asthma and CRSwNP. Recent studies also suggest its effectiveness in treating EOM. We report a unique case of CI for EOM, in which the post-implant hearing threshold improved after the introduction of dupilumab. The patient was a 63-year-old man with a history of asthma and multiple nasal polypectomies. Eosinophils were detected in otorrhea samples from both ears, leading to an EOM diagnosis four years prior. Despite local corticosteroid therapy, his hearing gradually deteriorated. One month ago, he experienced sudden bilateral deafness and was referred to our hospital. The right tympanic membrane had a pinhole perforation but no otorrhea. CT showed a small amount of soft tissue density in the right middle ear, while the left side displayed cochlear osteolysis with soft tissue density. A right CI and myringoplasty were performed one and a half months after his visit. The cochleostomy revealed no perilymph leakage, confirming that the scala tympani was filled with granulation tissue. The electrode was inserted successfully despite the granulation, and all electrodes were placed correctly. Six months after CI, his hearing threshold with the cochlear implant remained poor at 67.5 dB. However, upon starting dupilumab therapy seven months postoperatively, his hearing threshold with the cochlear implant rapidly improved to 31.3 dB. Intraoperative findings suggested that the scala tympani was filled with granulation tissue, indicating significant cochlear inflammation due to EOM. The subsequent hearing improvement after introducing dupilumab may be attributed to the reduction or disappearance of granulation in the cochlea, allowing for effective electrical stimulation from the electrodes to the spiral ganglion. This case suggests the potential for improved postoperative hearing outcomes in CI for EOM when inflammation is effectively controlled with dupilumab.
  • Evaluation of quality of life for patients with resolved facial nerve palsy.
    Keishi Fujiwara; Shinya Morita; Atsushi Fukuda; Kimiko Hoshino; Makoto Kobayashi; Yuji Nakamaru; Yasushi Furuta; Akihiro Homma
    Auris, nasus, larynx, 51, 3, 456, 459, Jun. 2024, [International Magazine]
    English, Scientific journal, OBJECTIVES: The quality of life (QOL) for patients with resolved facial nerve palsy has not been evaluated adequately. The objective of this study is to investigate QOL for patients with resolved facial nerve palsy. METHODS: Forty-seven patients with resolved facial nerve palsy were included and the patients' QOL was evaluated using the Facial Clinimetric Evaluation Scale (FaCE Scale). RESULTS: Twenty-two of the 47 patients (46.8%) with resolved facial nerve palsy showed impaired QOL, especially in terms of facial comfort and eye comfort. In 10 cases followed-up after the condition was judged to be resolved, the median scores for the FaCE scale at the time the condition was judged to be resolved and at the last visit were 65.5 and 72, respectively. The mean durations from the onset of the palsy to diagnosis of cure and to the last visit were 2.4 ± 1.6 and 4.3 ± 2.2 months, respectively. There was a significant improvement in QOL after the condition was judged to be resolved. CONCLUSION: There were discrepancies between QOL and facial movement as evaluated by physicians in patients in whom facial nerve palsy was resolved as in patients with non-cured facial nerve palsy. Patients' QOL continued to improve even after physicians judged the condition to be resolved and this result indicated that there were cases where improvement in QOL was delayed in comparison to improvement in facial movement.
  • Evaluation of Semicircular Canal Function Using Video Head Impulse Test in Patients With Peripheral Vestibular Disorders Without Nystagmus.
    Keishi Fujiwara; Shinya Morita; Kimiko Hoshino; Atsushi Fukuda; Hideaki Takeda; Yuji Nakamaru; Akihiro Homma
    Cureus, 16, 6, e62786, Jun. 2024, [International Magazine]
    English, Scientific journal, Objectives This study aims to evaluate semicircular canal function using video head impulse test (vHIT) in patients with peripheral vestibular disorders without nystagmus. Methods Patients who underwent vHIT were enrolled in this study, and the proportion of abnormal findings on vHIT in patients without nystagmus was investigated. In addition, the results of vestibular testing were investigated in cases in which both vHIT and caloric testing were performed in patients without nystagmus. Results Forty-six patients (23.4%) of 197 patients who had no abnormal findings on the nystagmus tests, including the gaze nystagmus test, positional nystagmus test, and positioning nystagmus test, showed dysfunction in at least one semicircular canal on vHIT. The most frequent diagnosis was vestibular schwannoma (14/46, 30.4%), and cases with bilateral vestibular dysfunction were also included (12/46, 26.1%). A disorganized pattern of catch-up saccade was observed more frequently in patients with subjective symptoms of dizziness/vertigo compared to those without subjective symptoms. Although the sensitivity of vHIT was low compared to caloric testing, vHIT could detect isolated vertical canal dysfunction not detected by caloric testing. Conclusions vHIT is considered to be a useful test for patients without nystagmus, as vHIT could detect abnormalities in approximately one-quarter of patients without nystagmus. vHIT is considered to be one of the first tests to be performed following nystagmus testing, including the gaze nystagmus test, the positional nystagmus test, and the positioning nystagmus test. On the other hand, there are some cases in which vHIT shows no abnormality while caloric testing shows canal paresis. It is necessary to perform vHIT, bearing in mind that there are abnormalities that cannot be detected by vHIT alone.
  • Pre- and post-operative semicircular canal function evaluated by video head impulse test in patients with vestibular schwannoma.
    Keishi Fujiwara; Shinya Morita; Hiroaki Motegi; Shigeru Yamaguchi; Yukitomo Ishi; Kimiko Hoshino; Atsushi Fukuda; Makoto Kobayashi; Yuji Nakamaru; Miki Fujimura; Akihiro Homma
    Auris, nasus, larynx, 51, 3, 542, 547, Jun. 2024, [International Magazine]
    English, Scientific journal, OBJECTIVES: To evaluate pre- and post-operative semicircular canal function in patients with vestibular schwannoma (VS) by the video Head Impulse Test (vHIT). METHODS: Nineteen patients with VS who underwent surgery were enrolled in this study. The gain in vestibulo-ocular reflex (VOR) and the degree of scatter in catch-up saccades were examined pre- and post-operatively for the semicircular canals in VS patients. RESULTS: Ten of 19 cases (52.6 %) with VS were defined as demonstrating both superior vestibular nerve (SVN) and inferior vestibular nerve (IVN) impairment from the results of pre-operative vHIT. Hearing level and subjective vestibular symptoms showed significant correlations with pre-operative semicircular canal function. Compared to pre-operative vHIT results, VOR gains within 1 month after surgery were significantly reduced in all three canals; however, significant differences had disappeared in the anterior and posterior semicircular canals at 6 months after surgery. Cases of unknown origin had a significantly greater reduction in posterior semicircular canal function after surgery compared with those with disease of IVN origin. CONCLUSIONS: As vHIT could evaluate pre-operative vestibular nerve impairment, post-operative VOR gain reduction and the degree of vestibular compensation, semicircular canal function evaluated by vHIT provides a good deal of useful information regarding VS patients undergoing surgery compared to caloric testing, and vHIT should be performed pre- and post-operatively for patients with VS.
  • Validity of endoscopic ossiculoplasty immediately after its introduction for ossicular chain disruption.
    Atsushi Fukuda; Shinya Morita; Kimiko Hoshino; Keishi Fujiwara; Yuji Nakamaru; Akihiro Homma
    BMC surgery, 24, 1, 149, 149, 14 May 2024, [International Magazine]
    English, Scientific journal, BACKGROUND: Transcanal endoscopic ear surgery (TEES) reportedly requires a long learning curve and may be associated with more complications and longer operative times than microscopic ear surgery (MES). In this study, we aimed to examine the usefulness and validity of TEES for ossicular chain disruption in the early stages of its introduction in our institution. METHODS: TEES was performed on 11 ears (10 with congenital ossicular chain discontinuity and 1 with traumatic ossicular chain dislocation), and MES was performed with a retroauricular incision on 18 ears (6 with congenital ossicular chain discontinuity and 12 with traumatic ossicular chain dislocation) in a tertiary referral center. Postoperative hearing results, operative times, and postoperative hospital length of stay were retrospectively reviewed. The Mann-Whitney U test and Fisher's exact test was performed to compare variables between the TEES and MES groups. Pre- and postoperative air- and bone-conduction thresholds and the air-bone gap of each group were compared using the Wilcoxon signed-rank test. The Mann-Whitney U test and Wilcoxon signed-rank was performed to compare the pre- and postoperative air-bone gaps between the diagnoses. RESULTS: No significant differences in the postoperative air-conduction thresholds, bone-conduction thresholds, air-bone gaps, or incidence of air-bone gap ≤ 20 dB were observed between the TEES and MES groups. The air-conduction thresholds and air-bone gaps of the TEES group significantly improved postoperatively. The air-conduction thresholds and air-bone gaps of the MES group also significantly improved postoperatively. No significant difference was observed in the operative times between the groups (TEES group: median, 80 min; MES group: median, 85.5 min). The TEES group had a significantly shorter postoperative hospital stay (median, 2 days) than the MES group (median, 7.5 days). CONCLUSIONS: TEES was considered appropriate for the treatment of ossicular chain disruption, even immediately after its introduction at our institution. For expert microscopic ear surgeons, ossicular chain disruption may be considered a suitable indication for the introduction of TEES.
  • 真珠腫性中耳炎半規管瘻孔症例におけるvideo Head Impulse Testを用いた半規管機能評価
    藤原 圭志; 森田 真也; 干野 季美子; 福田 篤; 本間 明宏
    日本耳鼻咽喉科頭頸部外科学会会報, 127, 4, 617, 617, (一社)日本耳鼻咽喉科頭頸部外科学会, Apr. 2024
    Japanese
  • Neutrophil Extracellular Trap Formation and Deoxyribonuclease I Activity in Patients with Otitis Media with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Shinya Morita; Yuji Nakamaru; Atsushi Fukuda; Keishi Fujiwara; Masanobu Suzuki; Kimiko Hoshino; Aya Honma; Akira Nakazono; Akihiro Homma
    International archives of allergy and immunology, 185, 8, 810, 819, 2024, [Peer-reviewed], [International Magazine]
    English, Scientific journal, INTRODUCTION: No previous studies have evaluated the levels of neutrophil extracellular trap (NET) remnants or the importance of deoxyribonuclease (DNase) I activity based on the disease activity of otitis media with antineutrophil cytoplasmic antibody-associated vasculitis (OMAAV). The aim of this study was to explore the formation of NETs in the middle ear of patients with OMAAV during the onset and remission phases of the disease, with a particular focus on the relationships between the quantifiable levels of NET remnants and DNase I activity. METHODS: OMAAV patients were eligible for inclusion. Patients with otitis media with effusion (OME) were examined as controls. The levels of cell-free deoxyribonucleic acid (DNA), citrullinated-histone H3 (cit-H3)-DNA complex, and myeloperoxidase (MPO)-DNA complex were quantified using an enzyme-linked immunosorbent assay. DNase I activity was measured using a fluorometric method. RESULTS: The quantifiable levels of cell-free DNA, cit-H3-DNA complex, and MPO-DNA complex in the middle ear lavage of patients with OMAAV at onset were significantly higher than those in patients with OMAAV at remission and in patients with OME. DNase I activity in the patients with OMAAV at onset was significantly lower than those in patients with OMAAV at remission and OME and was negatively correlated with the level of MPO-DNA complex. CONCLUSIONS: This study suggests that NET remnants and DNase I activity may be potentially useful biomarkers for the diagnosis and disease activity of OMAAV., 50934544
  • 鼓室型グロムス腫瘍の3例
    小林 諒; 森田 真也; 福田 篤; 干野 季美子; 藤原 圭志; 中丸 裕爾; 本間 明宏
    日本耳科学会総会・学術講演会抄録集, 33回, 296, 296, (一社)日本耳科学会, Nov. 2023
    Japanese
  • 当科における耳小骨離断に対する経外耳道的内視鏡下耳科手術の成績
    福田 篤; 森田 真也; 干野 季美子; 小林 諒; 藤原 圭志; 中丸 裕爾; 本間 明宏
    日本耳科学会総会・学術講演会抄録集, 33回, 390, 390, (一社)日本耳科学会, Nov. 2023
    Japanese
  • Quantitative Evaluations of Vestibular Function in Patients With Petrous Apex Cholesterol Granulomas Treated With an Endoscopic Transsphenoidal Approach: A Report of Two Cases.
    Yuuki Fujiwara; Keishi Fujiwara; Hiroaki Motegi; Yukitomo Ishi; Shinya Morita; Kimiko Hoshino; Atsushi Fukuda; Yuji Nakamaru; Akihiro Homma
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 44, 8, 809, 812, 01 Sep. 2023, [International Magazine]
    English, Scientific journal, OBJECTIVE: We report two cases of petrous apex cholesterol granuloma (PACG) treated with an endoscopic transsphenoidal approach. Vestibular functions of the two patients were evaluated quantitatively by video Head Impulse Test (vHIT) and/or vestibular evoked myogenic potentials (VEMPs). PATIENTS: Two patients with PACG who experienced episodes of dizziness are presented. INTERVENTION: An endoscopic transsphenoidal approach to PACG. MAIN OUTCOME MEASURE: The preoperative and postoperative vestibular functions as evaluated by vHIT and VEMP. RESULTS: Two cases of PACG were treated by a transsphenoidal approach. The internal auditory canal was compressed by the PACG in both cases. The patients both experienced episodes of dizziness before surgery and preoperative vestibular testing including vHIT and VEMP indicated dysfunction of vestibular nerves. After surgery, their symptoms were completely resolved, and the vestibular testing results were improved. CONCLUSIONS: This article is noteworthy for being the first to publish quantitative vestibular function testing for patients with PACG with vestibular dysfunction. PACG may show various symptoms, with dizziness being one of the most common symptoms. In cases in which the internal auditory canal is compressed by the PACG, vestibular functions should be evaluated by vHIT and VEMP. In the present cases, dizziness was found to be resolved by surgery to release the compression on internal auditory canal. Based on the present cases, the transsphenoidal approach is considered to be both safe and effective.
  • Discrepancies in the caloric testing and video Head Impulse Test results in a case with bilateral lateral semicircular canal malformations.
    Keishi Fujiwara; Shinya Morita; Atsushi Fukuda; Kimiko Hoshino; Yuji Nakamaru; Akihiro Homma
    Auris, nasus, larynx, 50, 3, 463, 467, Jun. 2023, [International Magazine]
    English, Scientific journal, Lateral semicircular canal (LSCC) malformations represent one of the most common types of inner ear malformation. As many cases of LSCC malformations are asymptomatic, detailed vestibular functions in such cases remain unclear. We present a case with bilateral LSCC malformations for whom the function of each vestibular organ was evaluated by caloric testing, video Head Impulse Test (vHIT) and vestibular evoked myogenic potentials (VEMP). Caloric testing showed canal paresis of the left side, whereas vHIT showed bilateral normal semicircular canal function. The results of VEMP indicated left saccular dysfunction. Discrepancies in caloric testing and vHIT results were observed and these discrepancies are thought to be due to endolymphatic hydrops rather than vestibular hypofunction, similar to that in Meniere disease.
  • 疼痛を伴わなかった悪性外耳道炎例
    佐藤 禄; 福田 篤; 森田 真也; 藤原 圭志; 中丸 裕爾; 本間 明宏
    耳鼻咽喉科臨床, 116, 6, 567, 572, 耳鼻咽喉科臨床学会, Jun. 2023
    Japanese, 症例は76歳男性で、左耳漏、左顔面神経麻痺、嚥下困難の精査加療目的に当科入院となった。入院時、耳痛は認めなかったが、側頭骨CTで左外耳道前壁から鼓室前壁にかけて強い骨融解像を伴う軟部陰影が充満し、頭蓋底の一部にも骨融解像がみられた。第2病日に生検および左後壁保存型鼓室形成術IIIc型を施行し、病理組織所見・画像所見より悪性外耳道炎に合併した頭蓋底骨髄炎の診断に至った。術後は6週間にわたり抗菌薬の静注を続け、頭蓋底病変は改善傾向にあったため、内服に切り替え第52病日に軽快退院した。抗菌薬は内服開始2年後に終了し、顔面神経麻痺は回復し、抗菌薬中止後1年4ヵ月間にわたり明らかな再燃は認めなかった。
  • アブミ骨手術の術後成績の検討 とくにピストントリミングの有無との関連について
    小林 諒; 福田 篤; 森田 真也; 藤原 圭志; 中丸 裕爾; 本間 明宏
    耳鼻咽喉科臨床, 115, 9, 747, 752, 耳鼻咽喉科臨床学会, Sep. 2022
    Japanese, 対象は2014年1月~2021年3月の39例44耳(男性10例、女性29例、平均年齢41.8歳)。診断は耳硬化症が30耳、耳小骨奇形が14耳であり、全例で顕微鏡下にstapedotomyを施行しCO2レーザーを用いてアブミ骨底板を開窓した。平均気導聴力は術前58.3dBから術後36.2dBと有意な改善を認めたが、平均骨導聴力は術後有意な変化を認めなかった。平均気骨導差は術前30.5dBから術後8.4dBと有意な改善を認めた。日本耳科学会基準に基づく術後成功例は36耳(81.8%)であった。術後聴力成績に影響を及ぼす因子として、テフロンピストンのリングをトリミングした場合に成功率が有意に低かった。ピストンリングのトリミングを行い成功に至らなかった症例のなかにはキヌタ骨長脚からピストンが脱落している症例もあり、テフロンピストンリングはできる限りトリミングせずに使用することが望ましい。
  • Association of gene mutations with clinicopathologic features in patients with external auditory canal squamous cell carcinoma.
    Shinya Morita; Satoshi Kano; Kanako C Hatanaka; Yutaka Hatanaka; Takayoshi Suzuki; Atsushi Fukuda; Kimiko Hoshino; Keishi Fujiwara; Yuji Nakamaru; Akihiro Homma
    International journal of clinical oncology, 27, 9, 1394, 1403, Sep. 2022, [Domestic magazines]
    English, Scientific journal, BACKGROUND: External auditory canal squamous cell carcinoma (EACSCC) is a rare form of malignant tumor. Due to the extremely limited understanding of the genomic landscape in EACSCC, the association between gene mutations and clinicopathologic features remains unclear. This study aimed to explore somatic gene mutations associated with the clinicopathological features in patients with EACSCC, and to identify the candidate gene mutations for predicting survival outcome in EACSCC. METHODS: Twenty-two tissue samples obtained from patients with EACSCC were analyzed for genetic mutations based on targeted next-generation sequencing and genetic expression based on IHC staining to investigate the driver of tumorigenesis and/or the candidates of genes for predicting clinical outcome in EACSCC. RESULTS: Gene alterations were most frequently observed in TP53 (59.1%), followed by CREBBP (9.1%). TP53 mutations showed significant correlation with T classification (P = 0.027) and p53 expression phenotype (P < 0.001). The 5-year overall survival (OS) rates for EACSCC patients with TP53 mutations and wild-type TP53 were 45.0% and 75.0%, respectively. Multivariable analysis using the Cox proportional hazards model demonstrated that TP53 mutations were independent predictors of OS rates for EACSCC patients (P = 0.007). CONCLUSION: This study has suggested that TP53 mutations have potential for use as a biomarker for identifying individuals at high risk of developing tumors and for predicting survival outcome in EACSCC. IHC staining for p53 might play a useful role as screening tool for detecting TP53 mutations in patients with EACSCC.
  • Evaluation of Semicircular Canal Function by Video Head Impulse Test in Patients With Labyrinthine Fistula Due to Cholesteatoma.
    Keishi Fujiwara; Shinya Morita; Atsushi Fukuda; Kimiko Hoshino; Yuji Nakamaru; Akihiro Homma
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 43, 5, 587, 593, 01 Jun. 2022, [International Magazine]
    English, Scientific journal, OBJECTIVES: To evaluate semicircular canal function in patients with labyrinthine fistula (LF) due to cholesteatoma by the video Head Impulse Test (vHIT). STUDY DESIGN: Retrospective case review. SETTING: Tertiary referral center. PATIENTS: Ten patients with LF due to cholesteatoma and six without LF underwent vestibular examination. INTERVENTION: Diagnostic. MAIN OUTCOME MEASURES: The gain in vestibulo-ocular reflex (VOR) and the presence of catch-up saccade were examined for the semicircular canals in patients with LF. RESULTS: Seven of 10 cases (70.0%) in the fistula group were judged to have semicircular canal dysfunction based on preoperative evaluation. VOR gains in the patients with LF were significantly lower than those in the patients without LF. VOR gain decreased significantly in accordance with the severity of the LF. The postoperative VOR gain more than 6 months after surgery was significantly improved compared with the preoperative VOR gain. CONCLUSIONS: The vHIT is thought to be the most suitable method for evaluating semicircular canal function in patients with LF due to cholesteatoma as it is not influenced by middle ear pathology and can evaluate the function of the vertical canals. The vHIT could predict whether a LF is present or not before surgery, and the vHIT is essential for surgery for patients with LF.
  • Discrepancies in the caloric testing and video Head Impulse Test results in a case with bilateral lateral semicircular canal malformations.
    Keishi Fujiwara; Shinya Morita; Atsushi Fukuda; Kimiko Hoshino; Yuji Nakamaru; Akihiro Homma
    Auris, nasus, larynx, 22 Apr. 2022, [International Magazine]
    English, Lateral semicircular canal (LSCC) malformations represent one of the most common types of inner ear malformation. As many cases of LSCC malformations are asymptomatic, detailed vestibular functions in such cases remain unclear. We present a case with bilateral LSCC malformations for whom the function of each vestibular organ was evaluated by caloric testing, video Head Impulse Test (vHIT) and vestibular evoked myogenic potentials (VEMP). Caloric testing showed canal paresis of the left side, whereas vHIT showed bilateral normal semicircular canal function. The results of VEMP indicated left saccular dysfunction. Discrepancies in caloric testing and vHIT results were observed and these discrepancies are thought to be due to endolymphatic hydrops rather than vestibular hypofunction, similar to that in Meniere disease.
  • Detailed clinical features and genotype-phenotype correlation in an OTOF-related hearing loss cohort in Japan.
    Yoh-Ichiro Iwasa; Shin-Ya Nishio; Hidekane Yoshimura; Akiko Sugaya; Yuko Kataoka; Yukihide Maeda; Yukihiko Kanda; Kyoko Nagai; Yasushi Naito; Hiroshi Yamazaki; Tetsuo Ikezono; Han Matsuda; Masako Nakai; Risa Tona; Yuika Sakurai; Remi Motegi; Hidehiko Takeda; Marina Kobayashi; Chiharu Kihara; Takashi Ishino; Shin-Ya Morita; Satoshi Iwasaki; Masahiro Takahashi; Sakiko Furutate; Shin-Ichiro Oka; Toshinori Kubota; Yasuhiro Arai; Yumiko Kobayashi; Daisuke Kikuchi; Tomoko Shintani; Noriko Ogasawara; Yohei Honkura; Shuji Izumi; Misako Hyogo; Yuzuru Ninoyu; Mayumi Suematsu; Jun Nakayama; Nana Tsuchihashi; Mayuri Okami; Hideaki Sakata; Hiroshi Yoshihashi; Taisuke Kobayashi; Kozo Kumakawa; Tadao Yoshida; Tomoko Esaki; Shin-Ichi Usami
    Human genetics, 141, 3-4, 865, 875, Apr. 2022, [International Magazine]
    English, Scientific journal, Mutations in the OTOF gene are a common cause of hereditary hearing loss and the main cause of auditory neuropathy spectrum disorder (ANSD). Although it is reported that most of the patients with OTOF mutations have stable, congenital or prelingual onset severe-to-profound hearing loss, some patients show atypical clinical phenotypes, and the genotype-phenotype correlation in patients with OTOF mutations is not yet fully understood. In this study, we aimed to reveal detailed clinical characteristics of OTOF-related hearing loss patients and the genotype-phenotype correlation. Detailed clinical information was available for 64 patients in our database who were diagnosed with OTOF-related hearing loss. As reported previously, most of the patients (90.6%) showed a "typical" phenotype; prelingual and severe-to-profound hearing loss. Forty-seven patients (73.4%) underwent cochlear implantation surgery and showed successful outcomes; approximately 85-90% of the patients showed a hearing level of 20-39 dB with cochlear implant and a Categories of Auditory Performance (CAP) scale level 6 or better. Although truncating mutations and p.Arg1939Gln were clearly related to severe phenotype, almost half of the patients with one or more non-truncating mutations showed mild-to-moderate hearing loss. Notably, patients with p.His513Arg, p.Ile1573Thr and p.Glu1910Lys showed "true" auditory neuropathy-like clinical characteristics. In this study, we have clarified genotype-phenotype correlation and efficacy of cochlear implantation for OTOF-related hearing loss patients in the biggest cohort studied to date. We believe that the clinical characteristics and genotype-phenotype correlation found in this study will support preoperative counseling and appropriate intervention for OTOF-related hearing loss patients.
  • Detailed clinical features and genotype-phenotype correlation in an OTOF-related hearing loss cohort in Japan.
    Yoh-Ichiro Iwasa; Shin-Ya Nishio; Hidekane Yoshimura; Akiko Sugaya; Yuko Kataoka; Yukihide Maeda; Yukihiko Kanda; Kyoko Nagai; Yasushi Naito; Hiroshi Yamazaki; Tetsuo Ikezono; Han Matsuda; Masako Nakai; Risa Tona; Yuika Sakurai; Remi Motegi; Hidehiko Takeda; Marina Kobayashi; Chiharu Kihara; Takashi Ishino; Shin-Ya Morita; Satoshi Iwasaki; Masahiro Takahashi; Sakiko Furutate; Shin-Ichiro Oka; Toshinori Kubota; Yasuhiro Arai; Yumiko Kobayashi; Daisuke Kikuchi; Tomoko Shintani; Noriko Ogasawara; Yohei Honkura; Shuji Izumi; Misako Hyogo; Yuzuru Ninoyu; Mayumi Suematsu; Jun Nakayama; Nana Tsuchihashi; Mayuri Okami; Hideaki Sakata; Hiroshi Yoshihashi; Taisuke Kobayashi; Kozo Kumakawa; Tadao Yoshida; Tomoko Esaki; Shin-Ichi Usami
    Human genetics, 141, 3-4, 865, 875, Apr. 2022, [International Magazine]
    English, Scientific journal, Mutations in the OTOF gene are a common cause of hereditary hearing loss and the main cause of auditory neuropathy spectrum disorder (ANSD). Although it is reported that most of the patients with OTOF mutations have stable, congenital or prelingual onset severe-to-profound hearing loss, some patients show atypical clinical phenotypes, and the genotype-phenotype correlation in patients with OTOF mutations is not yet fully understood. In this study, we aimed to reveal detailed clinical characteristics of OTOF-related hearing loss patients and the genotype-phenotype correlation. Detailed clinical information was available for 64 patients in our database who were diagnosed with OTOF-related hearing loss. As reported previously, most of the patients (90.6%) showed a "typical" phenotype; prelingual and severe-to-profound hearing loss. Forty-seven patients (73.4%) underwent cochlear implantation surgery and showed successful outcomes; approximately 85-90% of the patients showed a hearing level of 20-39 dB with cochlear implant and a Categories of Auditory Performance (CAP) scale level 6 or better. Although truncating mutations and p.Arg1939Gln were clearly related to severe phenotype, almost half of the patients with one or more non-truncating mutations showed mild-to-moderate hearing loss. Notably, patients with p.His513Arg, p.Ile1573Thr and p.Glu1910Lys showed "true" auditory neuropathy-like clinical characteristics. In this study, we have clarified genotype-phenotype correlation and efficacy of cochlear implantation for OTOF-related hearing loss patients in the biggest cohort studied to date. We believe that the clinical characteristics and genotype-phenotype correlation found in this study will support preoperative counseling and appropriate intervention for OTOF-related hearing loss patients.
  • Correction to: Detailed clinical features and genotype-phenotype correlation in an OTOF-related hearing loss cohort in Japan.
    Yoh-Ichiro Iwasa; Shin-Ya Nishio; Hidekane Yoshimura; Akiko Sugaya; Yuko Kataoka; Yukihide Maeda; Yukihiko Kanda; Kyoko Nagai; Yasushi Naito; Hiroshi Yamazaki; Tetsuo Ikezono; Han Matsuda; Masako Nakai; Risa Tona; Yuika Sakurai; Remi Motegi; Hidehiko Takeda; Marina Kobayashi; Chiharu Kihara; Takashi Ishino; Shin-Ya Morita; Satoshi Iwasaki; Masahiro Takahashi; Sakiko Furutate; Shin-Ichiro Oka; Toshinori Kubota; Yasuhiro Arai; Yumiko Kobayashi; Daisuke Kikuchi; Tomoko Shintani; Noriko Ogasawara; Yohei Honkura; Shuji Izumi; Misako Hyogo; Yuzuru Ninoyu; Mayumi Suematsu; Jun Nakayama; Nana Tsuchihashi; Mayuri Okami; Hideaki Sakata; Hiroshi Yoshihashi; Taisuke Kobayashi; Kozo Kumakawa; Tadao Yoshida; Tomoko Esaki; Shin-Ichi Usami
    Human genetics, 141, 3-4, 993, 995, Apr. 2022, [International Magazine]
    English
  • The Quantification of Extracellular Trap Cell Death-Derived Products as Diagnostic Biomarkers for Otitis Media With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Eosinophilic Otitis Media.
    Shinya Morita; Yuji Nakamaru; Atsushi Fukuda; Keishi Fujiwara; Masanobu Suzuki; Kimiko Hoshino; Aya Honma; Akihiro Homma
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 43, 3, e337-e343, 01 Mar. 2022, [International Magazine]
    English, Scientific journal, OBJECTIVE: This study aimed to quantify the cell-free deoxyribonucleic acid (DNA), citrullinated-histone H3 (cit-H3)-DNA complex, and myeloperoxidase (MPO)-DNA complex as extracellular trap cell death (ETosis)-derived products in the middle ear fluid, and to identify diagnostic biomarkers for the discrimination of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) from eosinophilic otitis media (EOM). STUDY DESIGN: Prospective study. SETTING: Tertiary referral center. PATIENTS: OMAAV patients were eligible for inclusion in this analysis. Patients with EOM were examined as controls. INTERVENTION: All samples were obtained from the middle ear fluid in patients with OMAAV or EOM. The fluid samples were aspirated from the middle ear through the anterior-inferior portion of the tympanic membrane using a 1-ml tuberculin syringe with a 24- or 26-gauge needle under a microscope. MAIN OUTCOME MEASURES: The levels of cell-free DNA, cit-H3-DNA complex and MPO-DNA complex in the fluid samples were quantified using an enzyme-linked immunosorbent assay. RESULTS: Patients with OMAAV showed significantly higher levels of MPO-DNA complex compared to patients with EOM, regardless of the serum ANCA status at the time of sampling (p < 0.001 and p < 0.001, respectively). Meanwhile, there were no significant differences in the values of cell-free DNA or cit-H3-DNA complex between the OMAAV and EOM patients. CONCLUSION: The findings of this study suggest that the detection and quantification of MPO-DNA complex in the otitis media fluid can be utilized to discriminate OMAAV, especially in cases of eosinophilic granulomatosis with polyangiitis, from EOM regardless of the serum ANCA status. It should be noted that it is possible for cell-free DNA and cit-H3-DNA complex in fluid samples to be derived from dead cells other than neutrophils that undergo ETosis.
  • Predictors of Survival in Favorable Risk Patients with Metastatic Renal Cell Carcinoma Treated with a Single-Agent First-Line Therapy.
    Ryuichi Mizuno; Kimiharu Takamatsu; Yota Yasumizu; Nobuyuki Tanaka; Toshikazu Takeda; Shinya Morita; Kazuhiro Matsumoto; Takeo Kosaka; Hiroshi Asanuma; Shuji Mikami; Mototsugu Oya
    Urologia internationalis, 1, 5, 09 Feb. 2022, [International Magazine]
    English, Scientific journal, INTRODUCTION: The aim of this retrospective study was to elucidate predictors of survival in metastatic renal cell carcinoma (mRCC) patients in an International Metastatic Renal Cell Carcinoma Database Consortium favorable risk group treated with frontline therapy without immune checkpoint inhibitors. METHODS: A total of 238 patients with mRCC were reviewed. Among them, 55 patients in favorable risk group treated with single-agent systemic therapy were retrospectively analyzed. Clinical and pathological data were retrieved and analyzed retrospectively. The prognostic effect of each marker on overall survival (OS) was investigated with univariate and multivariate Cox's proportional hazards regression models. RESULTS: After a median follow-up of 46.2 months after first-line treatment initiation, the median progression-free survival (PFS) was 29.3 months, and the median OS has not been reached. The estimated percentage of patients who were alive at 12 and 24 months were 96.1 and 94.1%, respectively. Multivariate analysis revealed that the long-term duration of first-line treatment (hazard ratio [HR]: 0.972, 95% confidence interval [CI]: 0.944-0.997, p = 0.0299) and the metastases limited to lung (HR: 3.852, 95% CI: 1.080-24.502, p = 0.0361) were independent predictors for longer OS in favorable risk mRCC patients. CONCLUSION: First-line systemic therapy for favorable risk mRCC patients with a single agent resulted in relatively longer PFS and OS. A longer duration of first-line treatment and lung only metastases are correlated with longer OS.
  • Psychological evaluation for patients with non-cured facial nerve palsy.
    Keishi Fujiwara; Atsushi Fukuda; Shinya Morita; Hiroko Yanagi; Kimiko Hoshino; Yuji Nakamaru; Yasushi Furuta; Akihiro Homma
    Auris, nasus, larynx, 49, 1, 53, 57, Feb. 2022, [International Magazine]
    English, Scientific journal, OBJECTIVE: The aim of the present study was to evaluate the psychological condition of patients with non-cured facial nerve palsy and to investigate whether their psychological condition is correlated with the degree of facial nerve palsy, synkinesis or quality of life. METHODS: Thirty patients with non-cured facial nerve palsy were enrolled in this study. Psychological conditions were evaluated by questionnaires including State-Trait Anxiety Inventory and Self-rating Depression Scale. RESULTS: Of the thirty patients with non-cured facial nerve palsy, 17 (56.7%) and 15 patients (50.0%) felt anxiety and depression, respectively. Although there were no significant correlations between their psychological condition and the degree of facial nerve palsy or that of sequelae, significant correlations were observed between psychological condition and the degree of QOL, especially in terms of social function. CONCLUSIONS AND SIGNIFICANCE: Disabilities associated with facial nerve palsy may be overlooked when evaluation is performed by physician-graded instruments alone. To resolve this problem, patients with non-cured facial nerve palsy should be evaluated by not only physician-graded tools but also patient-based assessment tools.
  • Characteristics of and Prognosis for Facial Palsy in Patients With Otitis Media With ANCA-Associated Vasculitis (OMAAV).
    Keishi Fujiwara; Shinya Morita; Atsushi Fukuda; Hiroko Yanagi; Kimiko Hoshino; Yuji Nakamaru; Yasushi Furuta; Akihiro Homma
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 42, 10, e1577-e1582, 01 Dec. 2021, [International Magazine]
    English, Scientific journal, OBJECTIVES: The aim of the present study was to investigate the characteristics and prognosis of facial palsy in patients with otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV). STUDY DESIGN: Retrospective case review. SETTING: Tertiary referral center. PATIENTS: Thirty-seven patients with OMAAV. MAIN OUTCOME MEASURES: The patients were divided into the facial palsy group and non-palsy group. The severity of and prognosis for facial palsy were evaluated using the House-Brackmann facial grading system (HB). Characteristics were compared between the facial palsy group and non-palsy group. RESULTS: Facial palsy was observed in eight patients. The last HB grade for all patients was either grade I or II after treatment with a combination of corticosteroids and immunosuppressant therapy. There were no cases in which palsy relapsed. Facial palsy in OMAAV was significantly more common in female patients, and patients with facial palsy demonstrated significantly higher rates of hypertrophic pachymeningitis than did those without facial palsy. CONCLUSIONS: Facial palsy in patients with OMAAV was detected in 21.6% and a good prognosis was obtained by use of the appropriate treatment. Facial palsy is one of the most important symptoms by which to diagnose OMAAV. When encountering the patients with intractable otitis media complicated with facial palsy, appropriate examination including ANCA titer should be performed.
  • 後天性中耳真珠腫におけるNotchシグナル関連分子発現についての検討
    福田 篤; 森田 真也; 藤原 圭志; 干野 季美子; 中丸 裕爾; 本間 明宏
    日本耳科学会総会・学術講演会抄録集, 31回, 422, 422, (一社)日本耳科学会, Oct. 2021
    Japanese
  • Notch Signaling in Acquired Middle Ear Cholesteatoma.
    Atsushi Fukuda; Satoshi Kano; Yuji Nakamaru; Shinya Morita; Kimiko Hoshino; Keishi Fujiwara; Akihiro Homma
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 42, 9, e1389-e1395, 01 Oct. 2021, [International Magazine]
    English, Scientific journal, HYPOTHESIS: We hypothesized that an anomalous change of Notch signaling might be involved in the pathophysiology of cholesteatoma. BACKGROUND: The Notch signaling pathway regulates integrated growth and differentiation control of keratinocytes. Its involvement in cholesteatoma proliferation has not been elucidated. METHODS: We obtained cholesteatoma and external auditory canal (EAC) skin samples from patients with middle ear cholesteatoma who underwent tympanomastoid surgery. We performed polymerase chain reaction using the RT2 Profiler™ PCR Array Human Notch Signaling Pathway (Qiagen) in the cholesteatoma and EAC skin samples (n = 6 each). This was followed by immunohistochemical staining of Notch1, enhancer of split-1 (HES1), and p53 in 41 and 8 cholesteatoma and EAC skin samples, respectively. RESULTS: The fold change of Notch1 gene expression was lowest in cholesteatoma, with a statistically significant difference (p = 0.0424). Moreover, the fold change of HES1 expression decreased (p = 0.272). The positive rates of Notch1 and HES1 protein expressions in the cholesteatoma (48.5 ± 32.4% and 44.9 ± 17.8%, respectively) were significantly lower than in the EAC skin (83.4 ± 17.5% and 55.7 ± 7.1%, respectively) (p < 0.001 and p < 0.01). In contrast, the positive rate of p53 expression in the cholesteatoma (8.5 ± 11.4%) was significantly higher than in the EAC skin (0.5 ± 0.7%) (p < 0.001). CONCLUSION: The decreases in Notch1 and HES1 protein expression might play an important role in the hyperproliferative character of the keratinizing squamous epithelium in cholesteatoma. An increase in p53 might reflect the reaction to cellular hyperproliferation.
  • Characteristics of and Prognosis for Facial Palsy in Patients With Otitis Media With ANCA-Associated Vasculitis (OMAAV).
    Keishi Fujiwara; Shinya Morita; Atsushi Fukuda; Hiroko Yanagi; Kimiko Hoshino; Yuji Nakamaru; Yasushi Furuta; Akihiro Homma
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 42, 10, e1577-e1582, 04 Aug. 2021, [International Magazine]
    English, Scientific journal, OBJECTIVES: The aim of the present study was to investigate the characteristics and prognosis of facial palsy in patients with otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV). STUDY DESIGN: Retrospective case review. SETTING: Tertiary referral center. PATIENTS: Thirty-seven patients with OMAAV. MAIN OUTCOME MEASURES: The patients were divided into the facial palsy group and non-palsy group. The severity of and prognosis for facial palsy were evaluated using the House-Brackmann facial grading system (HB). Characteristics were compared between the facial palsy group and non-palsy group. RESULTS: Facial palsy was observed in eight patients. The last HB grade for all patients was either grade I or II after treatment with a combination of corticosteroids and immunosuppressant therapy. There were no cases in which palsy relapsed. Facial palsy in OMAAV was significantly more common in female patients, and patients with facial palsy demonstrated significantly higher rates of hypertrophic pachymeningitis than did those without facial palsy. CONCLUSIONS: Facial palsy in patients with OMAAV was detected in 21.6% and a good prognosis was obtained by use of the appropriate treatment. Facial palsy is one of the most important symptoms by which to diagnose OMAAV. When encountering the patients with intractable otitis media complicated with facial palsy, appropriate examination including ANCA titer should be performed.
  • Psychological evaluation for patients with non-cured facial nerve palsy.
    Keishi Fujiwara; Atsushi Fukuda; Shinya Morita; Hiroko Yanagi; Kimiko Hoshino; Yuji Nakamaru; Yasushi Furuta; Akihiro Homma
    Auris, nasus, larynx, 49, 1, 53, 57, 04 May 2021, [International Magazine]
    English, Scientific journal, OBJECTIVE: The aim of the present study was to evaluate the psychological condition of patients with non-cured facial nerve palsy and to investigate whether their psychological condition is correlated with the degree of facial nerve palsy, synkinesis or quality of life. METHODS: Thirty patients with non-cured facial nerve palsy were enrolled in this study. Psychological conditions were evaluated by questionnaires including State-Trait Anxiety Inventory and Self-rating Depression Scale. RESULTS: Of the thirty patients with non-cured facial nerve palsy, 17 (56.7%) and 15 patients (50.0%) felt anxiety and depression, respectively. Although there were no significant correlations between their psychological condition and the degree of facial nerve palsy or that of sequelae, significant correlations were observed between psychological condition and the degree of QOL, especially in terms of social function. CONCLUSIONS AND SIGNIFICANCE: Disabilities associated with facial nerve palsy may be overlooked when evaluation is performed by physician-graded instruments alone. To resolve this problem, patients with non-cured facial nerve palsy should be evaluated by not only physician-graded tools but also patient-based assessment tools.
  • Usefulness of the Video Head Impulse Test for the Evaluation of Vestibular Function in Patients With Otitis Media With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Keishi Fujiwara; Shinya Morita; Atsushi Fukuda; Hiroko Yanagi; Kimiko Hoshino; Yuji Nakamaru; Akihiro Homma
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 42, 4, e483-e488, 01 Apr. 2021, [International Magazine]
    English, Scientific journal, OBJECTIVES: To investigate usefulness of the video Head Impulse Test (vHIT) as a method for evaluating semicircular canal function in patients with otitis media with antineutrophil cytoplasmic antibody-associated vasculitis (OMAAV). STUDY DESIGN: Retrospective case review. SETTING: Tertiary referral center. PATIENTS: Fourteen patients with OMAAV underwent vestibular examination. MAIN OUTCOME MEASURES: The gain in vestibulo-ocular reflex (VOR) and the presence of catch-up saccade were examined for each semicircular canal. RESULTS: Seven (50.0%) of the 14 patients felt subjective symptoms of disequilibrium. Dysfunction in at least one semicircular canal was detected in all ears of the OMAAV patients evaluated by vHIT. Dysfunction in posterior semicircular canal was detected more frequently than that in the anterior or horizontal canal. There were no significant correlations between the gain in VOR and hearing loss. CONCLUSIONS: vHIT is thought to be the most suitable method for evaluating semicircular canal function in patients with OMAAV as vHIT is not influenced by middle ear pathology and was able to evaluate vertical canal function including the posterior canal.
  • Prognostic factors for duration of vertigo after stapes surgery via a time-to-event analysis.
    Atsushi Fukuda; Keishi Fujiwara; Shinya Morita; Kimiko Hoshino; Hiroko Yanagi; Yuji Nakamaru; Akihiro Homma
    Acta oto-laryngologica, 141, 3, 216, 221, Mar. 2021, [International Magazine]
    English, Scientific journal, BACKGROUND: Vertigo or dizziness after stapes surgery occurs sometimes, and it is generally temporary. However, while rare, it can be prolonged. AIMS/OBJECTIVES: To investigate the prognostic factors for duration of vertigo following stapedotomy using a time-to-event analysis. MATERIALS AND METHODS: The present study included a total of 35 primary ears (26 with otosclerosis and nine with congenital stapes fixation) from 31 patients. We assessed residual rates of nystagmus and complaints of subjective vestibular symptoms using Kaplan-Meier time-to-event methods. RESULTS: Postoperative spontaneous nystagmus was observed in 23 (65.7%) ears, and postoperative subjective vestibular symptoms were confirmed in 27 (77.1%) ears. The total mean duration of postoperative spontaneous nystagmus and subjective vestibular symptoms was 9.8 (range: 0-158) and 33.9 days (0-732), respectively. A history of stapes surgery in the opposite ear was a significant predictive factor for prolonged nystagmus and subjective vestibular symptoms (p = .0059 and p = .0146). CONCLUSIONS AND SIGNIFICANCE: For individuals with a history of stapes surgery in the opposite ear, spontaneous nystagmus and vertigo/dizziness sensations following stapedotomy may persist for a longer duration than in those without a history of stapes surgery in the opposite ear.
  • Comparison of clinical characteristics of the nasal manifestations of eosinophilic granulomatosis with polyangiitis (EGPA) and eosinophilic chronic rhinosinusitis (ECRS).
    Masanobu Suzuki; Akira Nakazono; Shinya Morita; Atsushi Fukuda; Aya Honma; Takayoshi Suzuki; Shogo Kimura; Yuji Nakamaru; Akihiro Homma
    Allergology international : official journal of the Japanese Society of Allergology, 70, 1, 143, 144, Jan. 2021, [International Magazine]
    English
  • Evaluation of the modified Pittsburgh classification for predicting the disease-free survival outcome of squamous cell carcinoma of the external auditory canal.
    Cindy H Nabuurs; Wietske Kievit; Nilou Labbé; C René Leemans; Conrad F G M Smit; Michiel W M van den Brekel; Robert J Pauw; Bernard F A M van der Laan; Jeroen C Jansen; Martin Lacko; Weibel W Braunius; Shinya Morita; Małgorzata Wierzbicka; Takuma Matoba; Nobuhiro Hanai; Robert P Takes; Henricus P M Kunst
    Head & neck, 42, 12, 3609, 3622, Dec. 2020, [International Magazine]
    English, Scientific journal, BACKGROUND: Squamous cell carcinoma (SCC) of the external auditory canal (EAC) is a rare disease, which is commonly classified with the modified Pittsburgh classification. Our aim was to evaluate the predictive performance of this classification in relation to disease-free survival (DFS). METHODS: We examined retrospective data from a nationwide Dutch cohort study including patients with primary EAC SCC. These data were combined with individual patient data from the literature. Using the combined data, the predictive performances were calculated using the c-index. RESULTS: A total of 381 patients were included, 294 for clinical and 281 for the pathological classification analyses. The c-indices of the clinical and the pathological modified Pittsburgh classification predicting DFS were 0.725 (0.668-0.782) and 0.729 (0.672-0.786), respectively. CONCLUSION: The predictive performance of the modified Pittsburgh classification system as such appears to be acceptable to predict the DFS of EAC SCC. Other factors need to be added to a future model to improve the predicted performance.
  • video Head Impulse Testを用いたOMAAV症例の半規管機能評価
    藤原 圭志; 柳 紘子; 森田 真也; 干野 季美子; 福田 篤; 中丸 裕爾; 本間 明宏
    日本耳鼻咽喉科学会会報, 123, 4, 1142, 1142, (一社)日本耳鼻咽喉科頭頸部外科学会, Sep. 2020
    Japanese
  • Preoperative Pulmonary Function Testing to Predict Recurrence of Chronic Rhinosinusitis With Nasal Polyps
    Yuji Nakamaru; Masanobu Suzuki; Aya Honma; Akira Nakazono; Shogo Kimura; Keishi Fujiwara; Shinya Morita; Satoshi Konno; Akihiro Homma
    ALLERGY & RHINOLOGY, 11, Jul. 2020
    English, Scientific journal
  • Evaluation of Semicircular Canal Function by Video Head Impulse Test in Patients With Facial Nerve Schwannoma.
    Keishi Fujiwara; Shinya Morita; Yasushi Furuta; Hiroko Yanagi; Kimiko Hoshino; Atsushi Fukuda; Yuji Nakamaru; Akihiro Homma
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 41, 5, e615-e622, Jun. 2020, [International Magazine]
    English, Scientific journal, OBJECTIVES: The aim of the present study was to evaluate semicircular canal function by video Head Impulse Test (vHIT) in patients with facial nerve schwannoma (FNS). STUDY DESIGN: Retrospective case review. SETTING: Tertiary referral center. PATIENTS: Seven patients with FNS underwent vHIT examination. MAIN OUTCOME MEASURES: The gain in vestibulo-ocular reflex and the presence of catch-up saccade were examined for the semicircular canals including the vertical canals. RESULTS: Dysfunction of the semicircular canals was detected by vHIT in three of seven cases. Nystagmus beating toward the non-affected side was observed in all three cases with semicircular canal dysfunction. Dysfunction was observed in a case with no direct compression of the vestibular nerve or semicircular canals by FNS. CONCLUSIONS: Semicircular canal function in patients with FNS could be evaluated by vHIT. vHIT has two advantages for the evaluation of vestibular function in patients with FNS. First, vHIT could be used for the patients in whom a tumor exists in the external auditory canal or middle ear, unlike caloric testing. Second, as vHIT could evaluate all three canals, impaired vestibular nerves could be speculated from vHIT results when a tumor exists in internal auditory canal. vHIT should be performed in patients with FNS, especially before surgery, to evaluate vestibular function.
  • Clinical Characteristics and In Vitro Analysis of MYO6 Variants Causing Late-Onset Progressive Hearing Loss.
    Shin-Ichiro Oka; Timothy F Day; Shin-Ya Nishio; Hideaki Moteki; Maiko Miyagawa; Shinya Morita; Shuji Izumi; Tetsuo Ikezono; Satoko Abe; Jun Nakayama; Misako Hyogo; Nobuhiko Okamoto; Natsumi Uehara; Chie Oshikawa; Shin-Ichiro Kitajiri; Shin-Ichi Usami
    Genes, 11, 3, 04 Mar. 2020, [International Magazine]
    English, Scientific journal, MYO6 is known as a genetic cause of autosomal dominant and autosomal recessive inherited hearing loss. In this study, to clarify the frequency and clinical characteristics of hearing loss caused by MYO6 gene mutations, a large-scale genetic analysis of Japanese patients with hearing loss was performed. By means of massively parallel DNA sequencing (MPS) using next-generation sequencing for 8074 Japanese families, we found 27 MYO6 variants in 33 families, 22 of which are novel. In total, 2.40% of autosomal dominant sensorineural hearing loss (ADSNHL) in families in this study (32 out of 1336) was found to be caused by MYO6 mutations. The present study clarified that most cases showed juvenile-onset progressive hearing loss and their hearing deteriorated markedly after 40 years of age. The estimated hearing deterioration was found to be 0.57 dB per year; when restricted to change after 40 years of age, the deterioration speed was accelerated to 1.07 dB per year. To obtain supportive evidence for pathogenicity, variants identified in the patients were introduced to MYO6 cDNA by site-directed mutagenesis and overexpressed in epithelial cells. They were then assessed for their effects on espin1-induced microvilli formation. Cells with wildtype myosin 6 and espin1 co-expressed created long microvilli, while co-expression with mutant constructs resulted in severely shortened microvilli. In conclusion, the present data clearly showed that MYO6 is one of the genes to keep in mind with regard to ADSNHL, and the molecular characteristics of the identified gene variants suggest that a possible pathology seems to result from malformed stereocilia of the cochlear hair cells.
  • Preoperative Pulmonary Function Testing to Predict Recurrence of Chronic Rhinosinusitis With Nasal Polyps.
    Yuji Nakamaru; Masanobu Suzuki; Aya Honma; Akira Nakazono; Shogo Kimura; Keishi Fujiwara; Shinya Morita; Satoshi Konno; Akihiro Homma
    Allergy & rhinology (Providence, R.I.), 11, 2152656720946994, 2152656720946994, 2020, [International Magazine]
    English, Scientific journal, BACKGROUND: Although the close relationship between the upper and lower airways has been highlighted previously, little is known about the association between lung function and the recurrence of chronic rhinosinusitis with nasal polyps (CRSwNP). This study aimed to evaluate the factors associated with pulmonary function that affect CRSwNP recurrence after surgery. METHODS: We performed a series of routine pulmonary function tests for general anesthesia prior to CRSwNP surgery. The values for each parameter were compared in the presence or absence of recurrence. RESULTS: Sixty-nine patients with CRSwNP were included. The percent predicted forced expiratory volume in one second (%FEV1) in the recurrent group was significantly lower than that in the non-recurrent group (P = .005). A multivariable logistic regression model revealed that %FEV1 was a positive predictor of recurrence (odds ratio: 0.96, 95% CI: 0.92-0.99, P = .023). There were no significant differences in the other pulmonary functions between the two groups. CONCLUSIONS: We found that %FEV1 may be a predictor of CRSwNP recurrence after surgery. As %FEV1 is a pulmonary function test that is routinely performed before surgery, this parameter is readily applicable. Moreover, as %FEV1 appears to have the potential to reveal concealed asthma, %FEV1 might be a particularly useful tool for the prediction of CRSwNP recurrence after surgery.
  • Analysis of semicircular canal function as evaluated by video Head Impulse Test in patients with vestibular schwannoma.
    Keishi Fujiwara; Shinya Morita; Atsushi Fukuda; Hiroki Akamatsu; Hiroko Yanagi; Kimiko Hoshino; Yuji Nakamaru; Satoshi Kano; Akihiro Homma
    Journal of vestibular research : equilibrium & orientation, 30, 2, 101, 108, 2020, [International Magazine]
    English, Scientific journal, OBJECTIVE: The aim of the present study was to investigate the factors influencing semicircular canal function as evaluated by video Head Impulse Test (vHIT) in patients with vestibular schwannoma. METHODS: Twenty-four patients with untreated vestibular schwannoma underwent vHIT examination. The correlations between semicircular canal function and factors including age, tumor size, disease duration and hearing loss were evaluated. RESULTS: The functions of all three semicircular canals on the affected side evaluated by vHIT were significantly lower than those on the unaffected side. Although there were no significant correlations between semicircular canal function and age, tumor size or disease duration, a negative significant correlation between vestibulo-ocular reflex (VOR) gain as evaluated by vHIT and hearing loss was observed. CONCLUSIONS: From the results of the relationship between hearing loss and VOR gain, the damage to the audio and vestibular systems in patients with VS may be correlated. As it has been suggested that tumor size was not a significant factor in the VOR gain evaluated by vHIT, multifactorial causes rather than the simple compression of the vestibular nerves alone may be related to the dysfunction of the semicircular canals in patients with vestibular schwannoma.
  • 好酸球性中耳炎(EOM)と中耳炎を合併した好酸球性多発血管炎性肉芽腫症(EGPA)の比較
    福田 篤; 森田 真也; 藤原 圭志; 干野 季美子; 中丸 裕爾; 本間 明宏
    日本耳科学会総会・学術講演会抄録集, 29回, 508, 508, (一社)日本耳科学会, Oct. 2019
    Japanese
  • 当科における局所進行外耳道扁平上皮癌の治療成績の検討
    加納 里志; 森田 真也; 中丸 裕爾; 水町 貴諭; 対馬 那由多; 鈴木 崇祥; 中薗 彬; 福田 篤; 安田 耕一; 鬼丸 力也; 白土 博樹; 本間 明宏
    頭頸部癌, 45, 3, 300, 304, (一社)日本頭頸部癌学会, Oct. 2019
    Japanese
  • 【二次出版】ANL Secondary Publication 急性感音難聴患者における抗ムンプスIgM抗体陽性率 北海道における後向き多施設共同研究
    福田 篤; 森田 真也; 中丸 裕爾; 干野 季美子; 藤原 圭志; 赤澤 茂; 坂下 智博; 小原 修幸; 本間 明宏
    日本耳鼻咽喉科学会会報, 122, 9, 1267, 1268, (一社)日本耳鼻咽喉科学会, Sep. 2019
    Japanese
  • Differentiation Between Eosinophilic Otitis Media and Otitis Media Associated With Eosinophilic Granulomatosis With Polyangiitis.
    Atsushi Fukuda; Shinya Morita; Yuji Nakamaru; Kimiko Hoshino; Keishi Fujiwara; Akihiro Homma
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 40, 8, e796-e802, Sep. 2019, [International Magazine]
    English, Scientific journal, OBJECTIVE: To perform comparisons and clarify differences in clinical manifestations between eosinophilic otitis media (EOM) and otitis media associated with eosinophilic granulomatosis with polyangiitis (EGPA). STUDY DESIGN: Retrospective case review. SETTING: Tertiary referral center. PATIENTS: Twenty-two ears of 11 patients exhibiting EOM (EOM group) and 20 ears of 12 patients exhibiting otitis media associated with EGPA (EGPA group). MAIN OUTCOME MEASURES: Otological manifestations, nasal and paranasal manifestations, incidence of asthma, positivity for serum antineutrophil cytoplasmic antibodies (ANCA), total serum immunoglobulin (Ig) E level, peripheral blood eosinophil fraction, and hearing outcomes. RESULTS: The incidence and age of onset of asthma and chronic rhinosinusitis were comparable between the EOM and EGPA groups. Moreover, otological findings and hearing outcomes at the initial visit were similar in both groups. Computed tomography images of the paranasal sinus showed predominant opacification of the ethmoid sinus in both groups. Although the total serum IgE level was not significantly different, the peripheral blood eosinophil fraction was significantly larger in the EGPA group than in the EOM group (p = 0.0035). Furthermore, the rate of myeloperoxidase-antineutrophil cytoplasmic antibodies (ANCA) positivity was significantly higher in the EGPA group than in the EOM group (p = 0.019). CONCLUSIONS: The findings of the present study suggest that the phenotypic characteristics of EOM closely resemble those of otitis media associated with EGPA in early stages before the appearance of vasculitis. Therefore, it is challenging to differentiate the two conditions purely on the basis of otorhinological examinations.
  • Make-Up Therapy for Patients With Facial Nerve Palsy.
    Keishi Fujiwara; Yasushi Furuta; Wakae Aoki; Yuji Nakamaru; Shinya Morita; Kimiko Hoshino; Atsushi Fukuda; Akihiro Homma
    The Annals of otology, rhinology, and laryngology, 128, 8, 721, 727, Aug. 2019, [International Magazine]
    English, Scientific journal, OBJECTIVES: To investigate the effectiveness of make-up therapy for patients with facial nerve palsy. METHODS: Seven female patients with facial nerve palsy who received specialist make-up therapy were enrolled. The objective of the make-up therapy was to obtain a symmetrical facial appearance. RESULTS: Overall score for the Facial Clinimetric Evaluation (FaCE) scale was significantly improved after make-up therapy. There was a tendency for symptoms of depression to be improved among patients after make-up therapy. CONCLUSION: Make-up therapy to improve the symmetry of facial appearance could afford a noninvasive and low-cost treatment for patients with facial nerve palsy, especially in terms of patient quality of life and psychological condition.
  • ANCA関連血管炎性中耳炎における好中球細胞外トラップの測定と臨床応用
    森田 真也; 中丸 裕爾; 鈴木 正宣; 本間 明宏
    耳鼻咽喉科免疫アレルギー, 37, 2, 77, 78, 日本耳鼻咽喉科免疫アレルギー学会, Jun. 2019
    Japanese
  • Short-Term Hearing Prognosis of Ossiculoplasty in Pars Flaccida Cholesteatoma Using the EAONO/JOS Staging System.
    Atsushi Fukuda; Shinya Morita; Yuji Nakamaru; Kimiko Hoshino; Keishi Fujiwara; Akihiro Homma
    The journal of international advanced otology, 15, 1, 2, 7, Apr. 2019, [International Magazine]
    English, Scientific journal, OBJECTIVES: The aim of the present study was to investigate the prognostic factors for short-term hearing outcomes of ossiculoplasty for primary pars flaccida cholesteatoma according to the European Academy of Otology and Neurotology/Japanese Otological Society (EAONO/JOS) and 2015 JOS staging systems. MATERIALS AND METHODS: A total of 34 patients with primary pars flaccida cholesteatoma who underwent one-stage tympanomastoidectomy with partial ossicular reconstruction using double cartilage block were included in the study. The postoperative pure-tone average air-bone gap (PTA-ABG) was calculated, and two criteria of successful hearing outcomes were defined as ≤10 and ≤20 dB. Patients were classified according to the EAONO/JOS and 2015 JOS staging systems. Cochran-Armitage test was used to statistically analyze staging, and Fisher's exact test was used to analyze other factors. RESULTS: Successful hearing outcome with postoperative PTA-ABG ≤10 and ≤20 dB occurred in 23.5% and 55.9% of cases, respectively. When postoperative PTA-ABG ≤20 dB was defined as successful, the success rate significantly decreased with increase in EAONO/JOS stage, and S0 pathological status of the stapes (no involvement) was a significantly favorable predictive factor. When postoperative PTA-ABG ≤10 dB was regarded as successful, the significantly favorable predictive factors were S0 pathological status of the stapes and development of mastoid cells with MC2-3 (better developed cells). CONCLUSION: Favorable prognostic factors for hearing outcomes of tympanomastoidectomy with partial ossicular reconstruction for primary pars flaccida cholesteatoma were low stage following the EAONO/JOS staging system and no stapes involvement and better development of mastoid cells following the 2015 JOS staging system.
  • 好酸球性中耳炎EOMと中耳炎を合併した好酸球性多発血管炎性肉芽腫症EGPAの比較
    福田 篤; 森田 真也; 藤原 圭志; 干野 季美子; 中丸 裕爾; 本間 明宏
    日本耳鼻咽喉科学会会報, 122, 4, 627, 627, (一社)日本耳鼻咽喉科学会, Apr. 2019
    Japanese
  • video Head Impulse Testを用いた聴神経腫瘍患者の半規管機能評価
    藤原 圭志; 柳 紘子; 森田 真也; 干野 季美子; 福田 篤; 赤松 明樹; 中丸 裕爾; 本間 明宏
    日本耳鼻咽喉科学会会報, 122, 4, 704, 704, (一社)日本耳鼻咽喉科学会, Apr. 2019
    Japanese
  • Short-Term Hearing Prognosis of Ossiculoplasty in Pars Flaccida Cholesteatoma Using the EAONO/JOS Staging System.
    Fukuda A; Morita S; Nakamaru Y; Hoshino K; Fujiwara K; Homma A
    The journal of international advanced otology, 15, 1, 2, 7, Apr. 2019, [Peer-reviewed], [International Magazine]
    English, Scientific journal, OBJECTIVES: The aim of the present study was to investigate the prognostic factors for short-term hearing outcomes of ossiculoplasty for primary pars flaccida cholesteatoma according to the European Academy of Otology and Neurotology/Japanese Otological Society (EAONO/JOS) and 2015 JOS staging systems. MATERIALS AND METHODS: A total of 34 patients with primary pars flaccida cholesteatoma who underwent one-stage tympanomastoidectomy with partial ossicular reconstruction using double cartilage block were included in the study. The postoperative pure-tone average air-bone gap (PTA-ABG) was calculated, and two criteria of successful hearing outcomes were defined as ≤10 and ≤20 dB. Patients were classified according to the EAONO/JOS and 2015 JOS staging systems. Cochran-Armitage test was used to statistically analyze staging, and Fisher's exact test was used to analyze other factors. RESULTS: Successful hearing outcome with postoperative PTA-ABG ≤10 and ≤20 dB occurred in 23.5% and 55.9% of cases, respectively. When postoperative PTA-ABG ≤20 dB was defined as successful, the success rate significantly decreased with increase in EAONO/JOS stage, and S0 pathological status of the stapes (no involvement) was a significantly favorable predictive factor. When postoperative PTA-ABG ≤10 dB was regarded as successful, the significantly favorable predictive factors were S0 pathological status of the stapes and development of mastoid cells with MC2-3 (better developed cells). CONCLUSION: Favorable prognostic factors for hearing outcomes of tympanomastoidectomy with partial ossicular reconstruction for primary pars flaccida cholesteatoma were low stage following the EAONO/JOS staging system and no stapes involvement and better development of mastoid cells following the 2015 JOS staging system.
  • Evaluation of Vertical Semicircular Canal Function in Patients With Vestibular Schwannoma.
    Keishi Fujiwara; Hiroko Yanagi; Shinya Morita; Kimiko Hoshino; Atsushi Fukuda; Yuji Nakamaru; Akihiro Homma
    The Annals of otology, rhinology, and laryngology, 128, 2, 113, 120, Feb. 2019, [International Magazine]
    English, Scientific journal, OBJECTIVES:: The aim of this study was to investigate vertical semicircular canal function in patients with vestibular schwannoma (VS) by video head impulse test (vHIT). METHODS:: Fifteen patients with VS who had not received any treatment, including surgery or stereotactic radiotherapy, before vHIT examination were enrolled. Vestibulo-ocular reflex gain and catch-up saccade in vHIT were evaluated. RESULTS:: Dysfunction of anterior and posterior semicircular canals was detected by vHIT in 26.7% and 60.0%, respectively. Six patients (40.0%) demonstrated abnormalities referable to both vestibular nerve divisions. Abnormalities referable to the superior vestibular nerve were identified in 3 patients (20.0%), while 3 patients (20.0%) demonstrated a pattern indicative of inferior vestibular nerve involvement. Anterior semicircular canal vHIT produced fewer abnormalities than did either horizontal or posterior semicircular canal vHIT. CONCLUSIONS:: Dysfunction of the semicircular canals, including the vertical canals, in patients with VS was detected by vHIT. The anterior semicircular canal was less frequently involved than the horizontal or posterior semicircular canal. The examination of the vertical canals by vHIT is useful in the evaluation of vestibular function in patients with VS.
  • The Diagnostic and Clinical Utility of the Myeloperoxidase-DNA Complex as a Biomarker in Otitis Media With Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    Shinya Morita; Yuji Nakamaru; Daigo Nakazawa; Masanobu Suzuki; Kimiko Hoshino; Atsushi Fukuda; Fumihiko Hattanda; Kanako Kusunoki; Utano Tomaru; Akihiro Ishizu; Akihiro Homma
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 40, 2, e99-e106, Feb. 2019, [International Magazine]
    English, Scientific journal, OBJECTIVE: This prospective study aimed to evaluate the diagnostic and clinical utility of the myeloperoxidase (MPO)-DNA complex as a NETosis-derived product in the middle ear fluid of patients with otitis media with antineutrophil cytoplasmic antibody-associated vasculitis (OMAAV). STUDY DESIGN: Prospective study. SETTING: Tertiary referral center. PATIENTS: Twenty-two patients diagnosed with OMAAV. INTERVENTION: Collection of the fluid samples from middle ear. MAIN OUTCOME MEASURE: The levels of the MPO-DNA complex in the fluid samples were quantified using an enzyme-linked immunosorbent assay. RESULTS: Patients with both systemic and localized forms of OMAAV showed significantly higher levels of the MPO-DNA complex compared to the controls (p < 0.001 and p = 0.002, respectively). In particular, they showed significantly higher levels of MPO-DNA complex compared to the controls, regardless of serum antineutrophil cytoplasmic antibody status (p < 0.001 and p < 0.001, respectively) or immunosuppressive therapy (p < 0.001 and p < 0.001, respectively) at the time of sampling. An optical density cutoff value of 0.16 at 405 nm according to the receiver operating characteristic curve showed a sensitivity of 86.4%, specificity of 95.5%, positive predictive value of 95.0% and negative predictive value of 87.5% for the diagnosis of OMAAV. Significant positive correlations were observed between the levels of MPO-DNA complex and the values for air conduction - (r = 0.49, p = 0.022) and bone conduction - pure tone average thresholds (r = 0.45, p = 0.035). CONCLUSIONS: The detection and quantification of the MPO-DNA complex in the otitis media fluid may aid in providing a definite diagnosis as well as predicting the activity and severity of OMAAV.
  • Evaluation of Vertical Semicircular Canal Function in Patients With Vestibular Schwannoma.
    Fujiwara K; Yanagi H; Morita S; Hoshino K; Fukuda A; Nakamaru Y; Homma A
    The Annals of otology, rhinology, and laryngology, 128, 2, 113, 120, Feb. 2019, [Peer-reviewed], [International Magazine]
    English, Scientific journal, OBJECTIVES:: The aim of this study was to investigate vertical semicircular canal function in patients with vestibular schwannoma (VS) by video head impulse test (vHIT). METHODS:: Fifteen patients with VS who had not received any treatment, including surgery or stereotactic radiotherapy, before vHIT examination were enrolled. Vestibulo-ocular reflex gain and catch-up saccade in vHIT were evaluated. RESULTS:: Dysfunction of anterior and posterior semicircular canals was detected by vHIT in 26.7% and 60.0%, respectively. Six patients (40.0%) demonstrated abnormalities referable to both vestibular nerve divisions. Abnormalities referable to the superior vestibular nerve were identified in 3 patients (20.0%), while 3 patients (20.0%) demonstrated a pattern indicative of inferior vestibular nerve involvement. Anterior semicircular canal vHIT produced fewer abnormalities than did either horizontal or posterior semicircular canal vHIT. CONCLUSIONS:: Dysfunction of the semicircular canals, including the vertical canals, in patients with VS was detected by vHIT. The anterior semicircular canal was less frequently involved than the horizontal or posterior semicircular canal. The examination of the vertical canals by vHIT is useful in the evaluation of vestibular function in patients with VS.
  • The Diagnostic and Clinical Utility of the Myeloperoxidase-DNA Complex as a Biomarker in Otitis Media With Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    Morita S; Nakamaru Y; Nakazawa D; Suzuki M; Hoshino K; Fukuda A; Hattanda F; Kusunoki K; Tomaru U; Ishizu A; Homma A
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 40, 2, e99, e106, Feb. 2019, [Peer-reviewed], [International Magazine]
    English, Scientific journal, OBJECTIVE: This prospective study aimed to evaluate the diagnostic and clinical utility of the myeloperoxidase (MPO)-DNA complex as a NETosis-derived product in the middle ear fluid of patients with otitis media with antineutrophil cytoplasmic antibody-associated vasculitis (OMAAV). STUDY DESIGN: Prospective study. SETTING: Tertiary referral center. PATIENTS: Twenty-two patients diagnosed with OMAAV. INTERVENTION: Collection of the fluid samples from middle ear. MAIN OUTCOME MEASURE: The levels of the MPO-DNA complex in the fluid samples were quantified using an enzyme-linked immunosorbent assay. RESULTS: Patients with both systemic and localized forms of OMAAV showed significantly higher levels of the MPO-DNA complex compared to the controls (p < 0.001 and p = 0.002, respectively). In particular, they showed significantly higher levels of MPO-DNA complex compared to the controls, regardless of serum antineutrophil cytoplasmic antibody status (p < 0.001 and p < 0.001, respectively) or immunosuppressive therapy (p < 0.001 and p < 0.001, respectively) at the time of sampling. An optical density cutoff value of 0.16 at 405 nm according to the receiver operating characteristic curve showed a sensitivity of 86.4%, specificity of 95.5%, positive predictive value of 95.0% and negative predictive value of 87.5% for the diagnosis of OMAAV. Significant positive correlations were observed between the levels of MPO-DNA complex and the values for air conduction - (r = 0.49, p = 0.022) and bone conduction - pure tone average thresholds (r = 0.45, p = 0.035). CONCLUSIONS: The detection and quantification of the MPO-DNA complex in the otitis media fluid may aid in providing a definite diagnosis as well as predicting the activity and severity of OMAAV.
  • Spontaneous Regression of Swollen Submandibular Glands in IgG4-Related Disease.
    Masanobu Suzuki; Yuji Nakamaru; Dai Takagi; Aya Honma; Takayoshi Suzuki; Emi Takakuwa; Shinya Morita; Sarah Vreugde; Akihiro Homma
    Allergy & rhinology (Providence, R.I.), 10, 2152656718816738, 2152656718816738, 2019, [International Magazine]
    English, Scientific journal, BACKGROUND: IgG4-related disease is a new clinical entity frequently associated with swelling of the submandibular glands (SMGs). The long-term outcome of SMG swelling without steroid therapy remains unknown. OBJECTIVE: To examine whether swollen SMGs spontaneously regress without steroid therapy in the context of IgG4-related disease and to identify biomarkers that can predict the spontaneous regression of SMG swelling. METHODS: The SMG volume of 49 patients diagnosed with IgG4-related disease was calculated by measuring the axial and coronal planes of computed tomography scans. The change in SMG volume over time was measured and examined by treatment regimen, clinical data, and serum complement level. RESULTS: We found 28 of 49 (57%) IgG4-related disease patients to have swollen SMGs, with 15 of 20 (75%) of the swollen SMGs regressing without steroid therapy. The time required for the SMGs swelling to regress was significantly shorter in the steroid therapy group than in the no-steroid therapy group. Serum complement components at the initial visit were significantly lower in the regressed SMG group than in the nonregressed SMG group. CONCLUSION: We observed 75% of swollen SMGs spontaneously regressed in patients with IgG4-related disease. The time required for the swollen SMGs to regress was longer in patients without steroid therapy than in those with steroid therapy. Serum complement level could be used as a predictor for the spontaneous regression of swollen SMGs in patients with IgG4-related disease.
  • OTOF mutation analysis with massively parallel DNA sequencing in 2,265 Japanese sensorineural hearing loss patients.
    Yoh-Ichiro Iwasa; Shin-Ya Nishio; Akiko Sugaya; Yuko Kataoka; Yukihiko Kanda; Mirei Taniguchi; Kyoko Nagai; Yasushi Naito; Tetsuo Ikezono; Rie Horie; Yuika Sakurai; Rina Matsuoka; Hidehiko Takeda; Satoko Abe; Chiharu Kihara; Takashi Ishino; Shin-Ya Morita; Satoshi Iwasaki; Masahiro Takahashi; Tsukasa Ito; Yasuhiro Arai; Shin-Ichi Usami
    PloS one, 14, 5, e0215932, 2019, [Peer-reviewed], [International Magazine]
    English, Scientific journal, The OTOF gene (Locus: DFNB9), encoding otoferlin, is reported to be one of the major causes of non-syndromic recessive sensorineural hearing loss, and is also reported to be the most common cause of non-syndromic recessive auditory neuropathy spectrum disorder (ANSD). In the present study, we performed OTOF mutation analysis using massively parallel DNA sequencing (MPS). The purpose of this study was to reveal the frequency and precise genetic and clinical background of OTOF-related hearing loss in a large hearing loss population. A total of 2,265 Japanese sensorineural hearing loss (SNHL) patients compatible with autosomal recessive inheritance (including sporadic cases) from 53 otorhinolaryngology departments nationwide participated in this study. The mutation analysis of 68 genes, including the OTOF gene, reported to cause non-syndromic hearing loss was performed using MPS. Thirty-nine out of the 2,265 patients (1.72%) carried homozygous or compound heterozygous mutations in the OTOF gene. It is assumed that the frequency of hearing loss associated with OTOF mutations is about 1.72% of autosomal recessive or sporadic SNHL cases. Hearing level information was available for 32 of 39 patients with biallelic OTOF mutations; 24 of them (75.0%) showed profound hearing loss, 7 (21.9%) showed severe hearing loss and 1 (3.1%) showed mild hearing loss. The hearing level of patients with biallelic OTOF mutations in this study was mostly severe to profound, which is consistent with the results of past reports. Eleven of the 39 patients with biallelic OTOF mutations had been diagnosed with ANSD. The genetic diagnosis of OTOF mutations has significant benefits in terms of clinical decision-making. Patients with OTOF mutations would be good candidates for cochlear implantation; therefore, the detection of OTOF mutations is quite beneficial for patients, especially for those with ANSD.
  • Spontaneous Regression of Swollen Submandibular Glands in IgG4-Related Disease
    Masanobu Suzuki; Yuji Nakamaru; Dai Takagi; Aya Honma; Takayoshi Suzuki; Emi Takakuwa; Shinya Morita; Sarah Vreugde; Akihiro Homma
    Allergy & Rhinology, 10, 215265671881673, 215265671881673, SAGE Publications, Jan. 2019
    Scientific journal, Background IgG4-related disease is a new clinical entity frequently associated with swelling of the submandibular glands (SMGs). The long-term outcome of SMG swelling without steroid therapy remains unknown.

    Objective To examine whether swollen SMGs spontaneously regress without steroid therapy in the context of IgG4-related disease and to identify biomarkers that can predict the spontaneous regression of SMG swelling.

    Methods The SMG volume of 49 patients diagnosed with IgG4-related disease was calculated by measuring the axial and coronal planes of computed tomography scans. The change in SMG volume over time was measured and examined by treatment regimen, clinical data, and serum complement level.

    Results We found 28 of 49 (57%) IgG4-related disease patients to have swollen SMGs, with 15 of 20 (75%) of the swollen SMGs regressing without steroid therapy. The time required for the SMGs swelling to regress was significantly shorter in the steroid therapy group than in the no-steroid therapy group. Serum complement components at the initial visit were significantly lower in the regressed SMG group than in the nonregressed SMG group.

    Conclusion We observed 75% of swollen SMGs spontaneously regressed in patients with IgG4-related disease. The time required for the swollen SMGs to regress was longer in patients without steroid therapy than in those with steroid therapy. Serum complement level could be used as a predictor for the spontaneous regression of swollen SMGs in patients with IgG4-related disease.

  • Treatment outcomes of local advanced external auditory canal squamous cell carcinomas
    Satoshi Kano; Shinya Morita; Yuji Nakamaru; Takatsugu Mizumachi; Nayuta Tsushima; Takayoshi Suzuki; Akira Nakazono; Atsushi Fukuda; Koichi Yasuda; Rikiya Onimaru; Hiroki Shirato; Akihiro Homma
    Japanese Journal of Head and Neck Cancer, 45, 3, 300, 304, 2019, [Peer-reviewed]
    Scientific journal
  • Comparison of the University of Pittsburgh staging system and the eighth edition of the American Joint Committee on Cancer TNM classification for the prognostic evaluation of external auditory canal cancer.
    Shinya Morita; Takatsugu Mizumachi; Yuji Nakamaru; Tomohiro Sakashita; Satoshi Kano; Kimiko Hoshino; Atsushi Fukuda; Keishi Fujiwara; Akihiro Homma
    International journal of clinical oncology, 23, 6, 1029, 1037, Dec. 2018, [Domestic magazines]
    English, Scientific journal, BACKGROUND: The purpose was to compare survival differences between patients with external auditory canal (EAC) cancer treated according to the University of Pittsburgh modified TNM staging system and those treated in accordance with the 8th edition of the American Joint Committee on Cancer (AJCC) staging manual on the TNM staging system for cutaneous cancers of the head and neck. METHODS: We performed a retrospective, single-institution review of 60 patients with EAC cancer treated with curative intent between September 2002 and March 2018. Survival outcomes were measured on the basis of the two staging systems. RESULTS: The C-index values for the overall survival (OS) rate revealed that the University of Pittsburgh staging system had higher prognostic accuracy than the 8th edition of the AJCC staging system. Univariable and multivariable analysis showed that T classification according to the University of Pittsburgh staging system was an independent predictor of the OS rate (hazard ratio 5.25; 95% confidence interval 1.38-24.9; P = 0.015). Meanwhile, the AJCC staging system could not differentiate T2 from T3-4 cancers. CONCLUSION: The University of Pittsburgh staging system for patients with EAC cancer is a valuable tool for use in clinical decision-making and predicting survival outcome.
  • Anti-mumps IgM antibody positive rate with sudden sensorineural hearing loss using second-generation enzyme immunoassay: A retrospective, multi-institutional investigation in Hokkaido, Japan.
    Atsushi Fukuda; Shinya Morita; Yuji Nakamaru; Kimiko Hoshino; Keishi Fujiwara; Shigeru Akazawa; Tomohiro Sakashita; Nobuyuki Obara; Akihiro Homma
    Auris, nasus, larynx, 45, 5, 911, 915, Oct. 2018, [International Magazine]
    English, Scientific journal, OBJECTIVE: Although elevated anti-mumps IgM antibody levels were reported in 5.7%-7.2% of Japanese patients with sudden sensorineural hearing loss (SSNHL), there were several reports of false-positive cases, such as the continually IgM positive case and the IgM positive case in normal adults. To improve specificity, the new enzyme immuno assay (EIA) anti-mumps IgM antibody measurement kit was introduced in December 2009. This study re-examined the frequency of anti-mumps IgM antibody test positivity with SSNHL using the new measurement kit and compared the results with those from a previous report that used old kit. METHODS: This is a retrospective multi-institutional study involving patients diagnosed with SSNHL who exhibited the anti-mumps IgM antibody. We compared the positive rate of anti-mumps IgM antibody and the annual average number of mumps cases per sentinel in Hokkaido between the patients in the present study and patients previously evaluated. RESULTS: Overall, 100 patients with SSNHL were enrolled. One case (1.0%) was positive for anti-mumps IgM antibody. Of the 69 patients evaluated in the previous study, 5 cases (7.2%) were positive for anti-mumps IgM antibody. The positive rate of the anti-mumps IgM antibody in the present cases was significantly lower than that previously reported (p=0.042). The annual average number of mumps cases per sentinel in Hokkaido of the present and previous surveillance period was 34.47 and 42.77, respectively; no significant difference was seen in these data (p=0.4519). CONCLUSION: The present study revealed that 1.0% of SSNHL was positive for the anti-mumps IgM antibody using the new EIA-IgM measurement kit. After the introduction of the new EIA-IgM measurement kit, anti-mumps IgM antibody positive rate with SSNHL significantly decreased, indicating that the proportion of asymptomatic mumps among etiology of SSNHL may be lower than those previously reported.
  • Anti-mumps IgM antibody positive rate with sudden sensorineural hearing loss using second-generation enzyme immunoassay: A retrospective, multi-institutional investigation in Hokkaido, Japan
    Atsushi Fukuda; Shinya Morita; Yuji Nakamaru; Kimiko Hoshino; Keishi Fujiwara; Shigeru Akazawa; Tomohiro Sakashita; Nobuyuki Obara; Akihiro Homma
    Auris Nasus Larynx, 45, 5, 911, 915, Elsevier Ireland Ltd, 01 Oct. 2018, [Peer-reviewed]
    English, Scientific journal
  • EAONO/JOS中耳真珠腫進展度分類を用いた術後聴力予後因子の検討
    福田 篤; 森田 真也; 干野 季美子; 藤原 圭志; 中丸 裕爾; 本間 明宏
    Otology Japan, 28, 4, 468, 468, (一社)日本耳科学会, Sep. 2018
    Japanese
  • vHITを用いた聴神経腫瘍症例の垂直半規管機能評価
    藤原 圭志; 森田 真也; 干野 季美子; 福田 篤; 中丸 裕爾; 本間 明宏
    Otology Japan, 28, 4, 637, 637, (一社)日本耳科学会, Sep. 2018
    Japanese
  • Comparison of the University of Pittsburgh staging system and the eighth edition of the American Joint Committee on Cancer TNM classification for the prognostic evaluation of external auditory canal cancer.
    Morita S; Mizumachi T; Nakamaru Y; Sakashita T; Kano S; Hoshino K; Fukuda A; Fujiwara K; Homma A
    International journal of clinical oncology, 23, 6, 1029, 1037, Jul. 2018, [Peer-reviewed], [Domestic magazines]
    English, Scientific journal, BACKGROUND: The purpose was to compare survival differences between patients with external auditory canal (EAC) cancer treated according to the University of Pittsburgh modified TNM staging system and those treated in accordance with the 8th edition of the American Joint Committee on Cancer (AJCC) staging manual on the TNM staging system for cutaneous cancers of the head and neck. METHODS: We performed a retrospective, single-institution review of 60 patients with EAC cancer treated with curative intent between September 2002 and March 2018. Survival outcomes were measured on the basis of the two staging systems. RESULTS: The C-index values for the overall survival (OS) rate revealed that the University of Pittsburgh staging system had higher prognostic accuracy than the 8th edition of the AJCC staging system. Univariable and multivariable analysis showed that T classification according to the University of Pittsburgh staging system was an independent predictor of the OS rate (hazard ratio 5.25; 95% confidence interval 1.38-24.9; P = 0.015). Meanwhile, the AJCC staging system could not differentiate T2 from T3-4 cancers. CONCLUSION: The University of Pittsburgh staging system for patients with EAC cancer is a valuable tool for use in clinical decision-making and predicting survival outcome.
  • 当科における局所進行外耳道扁平上皮癌の治療成績の検討
    加納 里志; 森田 真也; 中丸 裕爾; 水町 貴諭; 中薗 彬; 福田 篤; 安田 耕一; 鬼丸 力也; 白土 博樹; 本間 明宏
    頭頸部癌, 44, 2, 181, 181, (一社)日本頭頸部癌学会, May 2018
    Japanese
  • 当科における局所進行外耳道扁平上皮癌の治療成績の検討
    加納 里志; 森田 真也; 中丸 裕爾; 水町 貴諭; 中薗 彬; 福田 篤; 安田 耕一; 鬼丸 力也; 白土 博樹; 本間 明宏
    頭頸部癌, 44, 2, 181, 181, (一社)日本頭頸部癌学会, May 2018
    Japanese
  • Elevated Level of Myeloperoxidase-Deoxyribonucleic Acid Complex in the Middle Ear Fluid Obtained From Patients With Otitis Media Associated With Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    Shinya Morita; Yuji Nakamaru; Daigo Nakazawa; Fumihiko Hattanda; Haruki Shida; Yoshihiro Kusunoki; Kanako Watanabe; Sakiko Masuda; Dai Takagi; Masanobu Suzuki; Kimiko Hoshino; Atsushi Fukuda; Utano Tomaru; Akihiro Homma; Akihiro Ishizu
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 39, 4, e257-e262, Apr. 2018, [International Magazine]
    English, Scientific journal, OBJECTIVE: The purpose was to explore the presence of myeloperoxidase (MPO)-deoxyribonucleic acid (DNA) complex as a surrogate marker of neutrophil extracellular traps (NETs) in the middle ear fluid, and to clarify the correlation between its quantifiable level and hearing outcome in patients with otitis media associated with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). STUDY DESIGN: Prospective study. SETTING: Tertiary referral center. PATIENTS: Nine AAV patients presenting with otitis media. INTERVENTION: Collection of the fluid samples from middle ear. MAIN OUTCOME MEASURE: The quantifiable levels of MPO-DNA complex using an enzyme-linked immunosorbent assay. RESULTS: The quantifiable levels of MPO-DNA complex in patients with AAV were significantly higher than those in controls (p < 0.001). In particular, both ANCA-positive and -negative cases indicated higher levels of MPO-DNA complex compared with the controls (p = 0.004 and p = 0.006, respectively). The significant negative correlations were observed between the level of MPO-DNA complex and the functional hearing values for air (r = -0.82, p = 0.009) and bone conduction (r = -0.73, p = 0.028), respectively. CONCLUSION: This analysis is the first to reveal the presence of elevated levels of MPO-DNA complex in the middle ear fluid, suggesting the pathogenic role of NETs in otitis media associated with AAV. NETs may be a valuable biomarker for use in clinical decision-making and predicting hearing outcome, regardless of ANCA status.
  • ANCA関連血管炎性中耳炎における好中球細胞外トラップの発現
    森田 真也; 中丸 裕爾; 干野 季美子; 福田 篤; 本間 明宏
    日本耳鼻咽喉科学会会報, 121, 4, 557, 557, (一社)日本耳鼻咽喉科学会, Apr. 2018
    Japanese
  • Elevated Level of Myeloperoxidase-Deoxyribonucleic Acid Complex in the Middle Ear Fluid Obtained from Patients with Otitis Media Associated with Antineutrophil Cytoplasmic Antibody-associated Vasculitis
    Shinya Morita; Yuji Nakamaru; Daigo Nakazawa; Fumihiko Hattanda; Haruki Shida; Yoshihiro Kusunoki; Kanako Watanabe; Sakiko Masuda; Dai Takagi; Masanobu Suzuki; Kimiko Hoshino; Atsushi Fukuda; Utano Tomaru; Akihiro Homma; Akihiro Ishizu
    Otology and Neurotology, 39, 4, e257, e262, Lippincott Williams and Wilkins, 01 Apr. 2018, [Peer-reviewed]
    English, Scientific journal
  • Clinical Characteristics and Treatment Outcomes for Patients With External Auditory Canal Cholesteatoma.
    Shinya Morita; Yuji Nakamaru; Atsushi Fukuda; Keishi Fujiwara; Kimiko Hoshino; Akihiro Homma
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 39, 2, 189, 195, Feb. 2018, [International Magazine]
    English, Scientific journal, OBJECTIVE: We aimed to evaluate the clinical features and treatment outcomes for patients with idiopathic and secondary external auditory canal cholesteatoma (EACC), and to validate the treatment strategy from the perspective of hearing as well as etiology and staging. STUDY DESIGN: Retrospective case series. SETTING: Tertiary referral center and affiliated hospitals. PATIENTS: Fifty-eight patients with idiopathic EACC and 14 patients with secondary EACC. INTERVENTION: Conservative management and surgery. MAIN OUTCOME MEASURE: Air conduction (AC) pure-tone averages (PTAs) and mean air-bone gaps (ABGs). RESULTS: There were no significant differences between hearing values before and after conservative management for idiopathic EACC patients with stages I-III, indicating that hearing abilities were preserved. For idiopathic EACC patients with stage IV disease treated with surgery, the AC PTA threshold and mean ABG significantly improved from a preoperative value of 60.3 dB HL to a postoperative value of 32.4 dB HL (p = 0.013), and from 34.3 to 9.5 dB HL (p < 0.001), respectively. For secondary EACC, the AC PTA threshold and mean ABG significantly improved from a preoperative value of 49.5 dB HL to a postoperative value of 23.2 dB HL (p < 0.001), and from 31.4 to 6.7 dB HL (p < 0.001), respectively. CONCLUSION: The treatment modalities should be selected based on the perspective of hearing as well as the extent of disease and etiology. The early lesions can be treated conservatively, whereas the advanced lesions or cases refractory to conservative management require complete surgical removal of EACC.
  • Clinical Characteristics and Treatment Outcomes for Patients with External Auditory Canal Cholesteatoma
    Shinya Morita; Yuji Nakamaru; Atsushi Fukuda; Keishi Fujiwara; Kimiko Hoshino; Akihiro Homma
    Otology and Neurotology, 39, 2, 189, 195, Lippincott Williams and Wilkins, 01 Feb. 2018, [Peer-reviewed]
    English, Scientific journal
  • WFS1 mutation screening in a large series of Japanese hearing loss patients: Massively parallel DNA sequencing-based analysis.
    Masafumi Kobayashi; Maiko Miyagawa; Shin-Ya Nishio; Hideaki Moteki; Taro Fujikawa; Kenji Ohyama; Hirofumi Sakaguchi; Ikuyo Miyanohara; Akiko Sugaya; Yasushi Naito; Shin-Ya Morita; Yukihiko Kanda; Masahiro Takahashi; Kotaro Ishikawa; Yuki Nagano; Tetsuya Tono; Chie Oshikawa; Chiharu Kihara; Haruo Takahashi; Yoshihiro Noguchi; Shin-Ichi Usami
    PloS one, 13, 3, e0193359, 2018, [Peer-reviewed], [International Magazine]
    English, Scientific journal, A heterozygous mutation in the Wolfram syndrome type 1 gene (WFS1) causes autosomal dominant nonsyndromic hereditary hearing loss, DFNA6/14/38, or Wolfram-like syndrome. To date, more than 40 different mutations have been reported to be responsible for DFNA6/14/38. In the present study, WFS1 variants were screened in a large series of Japanese hearing loss (HL) patients to clarify the prevalence and clinical characteristics of DFNA6/14/38 and Wolfram-like syndrome. Massively parallel DNA sequencing of 68 target genes was performed in 2,549 unrelated Japanese HL patients to identify genomic variations responsible for HL. The detailed clinical features in patients with WFS1 variants were collected from medical charts and analyzed. We successfully identified 13 WFS1 variants in 19 probands: eight of the 13 variants were previously reported mutations, including three mutations (p.A684V, p.K836N, and p.E864K) known to cause Wolfram-like syndrome, and five were novel mutations. Variants were detected in 15 probands (2.5%) in 602 families with presumably autosomal dominant or mitochondrial HL, and in four probands (0.7%) in 559 sporadic cases; however, no variants were detected in the other 1,388 probands with autosomal recessive or unknown family history. Among the 30 individuals possessing variants, marked variations were observed in the onset of HL as well as in the presence of progressive HL and tinnitus. Vestibular symptoms, which had been rarely reported, were present in 7 out of 30 (23%) of the affected individuals. The most prevalent audiometric configuration was low-frequency type; however, some individuals had high-frequency HL. Haplotype analysis in three mutations (p.A716T, p.K836T, and p.E864K) suggested that the mutations occurred at these mutation hot spots. The present study provided new insights into the audiovestibular phenotypes in patients with WFS1 mutations.
  • Value of T1-weighted Magnetic Resonance Imaging in Cholesteatoma Detection.
    Atsushi Fukuda; Shinya Morita; Taisuke Harada; Keishi Fujiwara; Kimiko Hoshino; Yuji Nakamaru; Akihiro Homma
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 38, 10, 1440, 1444, Dec. 2017, [International Magazine]
    English, Scientific journal, OBJECTIVE: To reveal the usefulness of T1-weighted (T1W) imaging on diagnostic magnetic resonance (MR) imaging for cholesteatoma. STUDY DESIGN: A retrospective case review. SETTING: Tertiary referral center. PATIENTS: Fifty-three patients (57 ears) suspected to have cholesteatomas and treated (6-82 yr of age). INTERVENTION: Preoperative MR imaging, including non-echo planar (non-EP) diffusion-weighted (DW) and T1W imaging. MAIN OUTCOME MEASURES: Primary outcome measures included the comparison between the diagnostic accuracy for the detection of cholesteatomas using non-EP DW imaging alone (criterion 1) and non-EP DW imaging along with T1W imaging (criterion 2). Diagnostic accuracy was evaluated in each case by comparing MR imaging with surgical findings. Secondary outcome measures included the comparison of the rates of cases showing a high T1W signal between cholesteatomas and noncholesteatomas which showed a high non-EP DW signal. RESULTS: The sensitivity, specificity, and accuracy according to criterion 1 were 93.5, 63.6, and 87.7% and those according to criterion 2 were 89.1, 100, and 91.2%, respectively. Of 43 cholesteatoma cases indicating a high non-EP DW signal, only 2 cases showed a high T1W signal (5%). On the other hand, all four noncholesteatoma cases indicating high non-EP DW signal showed a high T1W signal (100%), and these rates were significantly different (p < 0.001). CONCLUSION: Our results suggest that T1W imaging may aid in the exclusion of false-positive cases on diagnostic non-EP DW MR imaging for cholesteatomas. A combination of non-EP DW and T1W imaging may improve the specificity and accuracy compared with non-EP DW imaging alone.
  • Value of T1-weighted magnetic resonance imaging in cholesteatoma detection
    Atsushi Fukuda; Shinya Morita; Taisuke Harada; Keishi Fujiwara; Kimiko Hoshino; Yuji Nakamaru; Akihiro Homma
    Otology and Neurotology, 38, 10, 1440, 1444, Lippincott Williams and Wilkins, 01 Dec. 2017, [Peer-reviewed]
    English
  • 急性感音難聴患者におけるムンプスIgM抗体陽性率の検討(第2報)
    福田 篤; 森田 真也; 干野 季美子; 藤原 圭志; 赤澤 茂; 中丸 裕爾; 本間 明宏
    Otology Japan, 27, 4, 568, 568, (一社)日本耳科学会, Oct. 2017
    Japanese
  • 抗好中球細胞質抗体関連血管炎症候群に伴う難治性中耳炎における好中球細胞外トラップの発現
    森田 真也; 中丸 裕爾; 干野 季美子; 福田 篤; 本間 明宏
    Otology Japan, 27, 4, 429, 429, (一社)日本耳科学会, Oct. 2017
    Japanese
  • ムンプス難聴の臨床的特徴と予後
    森田 真也; 西尾 信哉; 鬼頭 良輔; 宇佐美 真一; 難治性聴覚障害に関す; 調査研究班
    Audiology Japan, 60, 5, 361, 361, (一社)日本聴覚医学会, Sep. 2017
    Japanese
  • Vogt-小柳-原田病における平衡機能障害に関する検討
    藤原 圭志; 森田 真也; 干野 季美子; 福田 篤; 福田 諭
    日本耳鼻咽喉科学会会報, 120, 4, 634, 634, (一社)日本耳鼻咽喉科学会, Apr. 2017
    Japanese
  • 外耳道癌組織における免疫組織化学的手法に基づく発現分子解析
    森田 真也; 本間 明宏; 中丸 裕爾; 安川 真一郎; 福田 篤; 福田 諭
    日本耳鼻咽喉科学会会報, 120, 4, 566, 566, (一社)日本耳鼻咽喉科学会, Apr. 2017
    Japanese
  • 当科の弛緩部型中耳真珠腫の臨床的検討
    福田 篤; 森田 真也; 干野 季美子; 藤原 圭志; 中丸 裕爾; 福田 諭
    日本耳鼻咽喉科学会会報, 120, 4, 535, 535, (一社)日本耳鼻咽喉科学会, Apr. 2017
    Japanese
  • Expression of p53, p16, cyclin D1, epidermal growth factor receptor and Notch1 in patients with temporal bone squamous cell carcinoma.
    Shinya Morita; Yuji Nakamaru; Akihiro Homma; Shinichiro Yasukawa; Hiromitsu Hatakeyama; Tomohiro Sakashita; Satoshi Kano; Atsushi Fukuda; Satoshi Fukuda
    International journal of clinical oncology, 22, 1, 181, 189, Feb. 2017, [Domestic magazines]
    English, Scientific journal, BACKGROUND: The aim of this study was to investigate the expression of p53, p16, cyclin D1, epidermal growth factor receptor (EGFR) and Notch1 in temporal bone squamous cell carcinoma (TBSCC) tissue samples by immunohistochemistry (IHC), and to evaluate the association between these biomarkers and clinicopathological features. METHODS: We performed a retrospective, single-institution review of 30 TBSCC patients treated with curative intent between April 2006 and March 2015. All tissue samples were obtained from pretreatment biopsy specimens or surgical specimens and using IHC staining. RESULTS: Ten patients were categorized as T1, seven as T2, five as T3 and eight as T4. Nine patients had clinically positive lymph node metastasis. The positive expression of p53 and EGFR was significantly associated with T classification (P = 0.042 and P = 0.0039). EGFR expression was significantly more frequent in patients with positive lymph node metastasis compared with patients without node involvement (P = 0.017). In the analysis of the association between protein expression by IHC staining and prognosis, the positive expression of EGFR and Notch1 was significantly correlated with poor survival outcomes in TBSCC (P = 0.015 and P = 0.025) CONCLUSION: Overexpression of p53 and EGFR may be valuable biomarkers for identifying individuals at high risk of developing tumors in TBSCC. Furthermore, the positive expression of EGFR was significantly associated with poor survival outcome. Anti-EGFR therapy has potential for use as the treatment modality of choice for advanced-stage TBSCC as well as other head and neck squamous cell carcinomas.
  • Expression of p53, p16, cyclin D1, epidermal growth factor receptor and Notch1 in patients with temporal bone squamous cell carcinoma
    Shinya Morita; Yuji Nakamaru; Akihiro Homma; Shinichiro Yasukawa; Hiromitsu Hatakeyama; Tomohiro Sakashita; Satoshi Kano; Atsushi Fukuda; Satoshi Fukuda
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 22, 1, 181, 189, Feb. 2017, [Peer-reviewed]
    English, Scientific journal
  • The clinical features and prognosis of mumps-associated hearing loss: a retrospective, multi-institutional investigation in Japan.
    Shinya Morita; Keishi Fujiwara; Atsushi Fukuda; Satoshi Fukuda; Shin-Ya Nishio; Ryosuke Kitoh; Naohito Hato; Tetsuo Ikezono; Kotaro Ishikawa; Kimitaka Kaga; Atsushi Matsubara; Tatsuo Matsunaga; Takaaki Murata; Yasushi Naito; Kazunori Nishizaki; Kaoru Ogawa; Hajime Sano; Hiroaki Sato; Michihiko Sone; Mikio Suzuki; Haruo Takahashi; Tetsuya Tono; Hiroshi Yamashita; Tatsuya Yamasoba; Shin-Ichi Usami
    Acta oto-laryngologica, 137, sup565, S44-S47, 2017, [International Magazine]
    English, Scientific journal, CONCLUSIONS: The majority of hearing loss due to mumps presents as unilateral profound sensorineural hearing loss, which is refractory to treatment. In rare cases of bilateral total deafness, cochlear implants were beneficial for speech perception. Vaccination against mumps is recommended to prevent mumps-associated hearing loss. OBJECTIVE: The objective of this study is to investigate the clinical characteristics of hearing loss due to mumps and to evaluate hearing outcomes. SUBJECTS AND METHODS: The clinical parameters were analyzed under a retrospective multi-institutional study design in patients diagnosed with hearing loss due to mumps at the Otolaryngology departments of 19 hospitals between 1987 and 2016. RESULTS: Sixty-seven patients with hearing loss due to mumps were enrolled. The study population consisted of 35 males and 32 females, ranging in age from 1 to 54, with a median age of 9.5 years. Sixty-three patients presented with unilateral, and 4 with bilateral hearing loss. Profound hearing loss was observed in 65 ears. Only one ear with severe hearing loss showed complete recovery. Four patients with bilateral hearing loss received cochlear implant surgery. Most of the patients with hearing loss due to mumps had no history of vaccination.
  • Evaluation of Vestibular Functions in Patients with Vogt-Koyanagi-Harada Disease.
    Keishi Fujiwara; Shinya Morita; Kimiko Hoshino; Atsushi Fukuda; Yuji Nakamaru; Akihiro Homma
    Audiology & neuro-otology, 22, 3, 190, 195, 2017, [International Magazine]
    English, Scientific journal, Vogt-Koyanagi-Harada (VKH) disease is an idiopathic, multisystem autoimmune disorder characterized by bilateral, diffuse granulomatous uveitis associated with neurological, audiovestibular, and dermatological manifestations. The purpose of this study is to investigate vestibular functions in patients with VKH disease. A total of 43 patients with VKH disease in Hokkaido University Hospital were enrolled in this study. Subjective symptoms such as dizziness or vertigo and the results of various vestibular examinations including nystagmus testing, caloric testing, and vestibular-evoked myogenic potential (VEMP) testing were investigated. Eight of 42 patients (19.0%) complained of subjective vestibular symptoms. On the other hand, 12 of 28 patients (42.9%) showed nystagmus, and 7 of 15 patients (46.7%) showed unilateral or bilateral weakness in the caloric test. VEMP testing was performed for 16 patients. Seven (43.8%) and 8 (50.0%) patients were evaluated as abnormal in cervical VEMP and ocular VEMP testing, respectively. The rate of detection of nystagmus was significantly higher than that of subjective symptoms. As vestibular dysfunction in patients with VKH disease cannot be detected through history taking alone, nystagmus testing, caloric testing, and VEMP testing should be performed to evaluate vestibular functions associated with VKH disease. It is considered that abnormal VEMP findings are associated with otolith organ dysfunction.
  • The clinical features and prognosis of mumps-associated hearing loss: a retrospective, multi-institutional investigation in Japan
    Shinya Morita; Keishi Fujiwara; Atsushi Fukuda; Satoshi Fukuda; Shin-ya Nishio; Ryosuke Kitoh; Naohito Hato; Tetsuo Ikezono; Kotaro Ishikawa; Kimitaka Kaga; Atsushi Matsubara; Tatsuo Matsunaga; Takaaki Murata; Yasushi Naito; Kazunori Nishizaki; Kaoru Ogawa; Hajime Sano; Hiroaki Sato; Michihiko Sone; Mikio Suzuki; Haruo Takahashi; Tetsuya Tono; Hiroshi Yamashita; Tatsuya Yamasoba; Shin-ichi Usami
    ACTA OTO-LARYNGOLOGICA, 137, sup565, S44, S47, 2017, [Peer-reviewed]
    English, Scientific journal
  • Evaluation of Vestibular Functions in Patients with Vogt-Koyanagi-Harada Disease
    Keishi Fujiwara; Shinya Morita; Kimiko Hoshino; Atsushi Fukuda; Yuji Nakamaru; Akihiro Homma
    AUDIOLOGY AND NEURO-OTOLOGY, 22, 3, 190, 195, 2017, [Peer-reviewed]
    English, Scientific journal
  • The Outcomes of Surgery and Chemoradiotherapy for Temporal Bone Cancer.
    Shinya Morita; Akihiro Homma; Yuji Nakamaru; Tomohiro Sakashita; Hiromitsu Hatakeyama; Satoshi Kano; Atsushi Fukuda; Satoshi Fukuda
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 37, 8, 1174, 82, Sep. 2016, [International Magazine]
    English, Scientific journal, OBJECTIVE: We aimed to evaluate the prognostic factors and efficacy of treatment modalities for patients with temporal bone cancer, and to determine if definitive chemoradiotherapy (CRT) for advanced-stage disease can provide a substitute for highly invasive surgeries. STUDY DESIGN: Retrospective case series. SETTING: Tertiary referral center. PATIENTS: Sixty-six patients with previously untreated squamous cell carcinoma of the temporal bone treated with curative intent between April 1997 and March 2015. INTERVENTION: Surgery alone, radiotherapy (RT) alone, surgery followed by RT or definitive CRT. MAIN OUTCOME MEASURE: The overall survival (OS) rate. RESULTS: The 5-year OS rate for each T classification was 100% for T1, 76.2% for T2, 55.6% for T3, and 36.7% for T4. Univariable and multivariable analysis showed that T classification was an independent predictor of the OS rate (hazard ratio 5.66; 95% confidence interval 1.51-27.0; p = 0.015). Analysis by treatment modality revealed that the 5-year OS rate for patients with T1-2 was 100% for surgery and 81.3% for RT alone. The rate for patients with T3-4 was 52.1% for definitive CRT and 55.6% for surgery followed by RT with or without chemotherapy. CONCLUSIONS: Patients with T1-2 benefited from surgical intervention without significant morbidity or mortality. Our findings also suggested that definitive CRT might be appropriate as the first-line treatment for T3-4, especially in cases with unresectable tumors.
  • 隣接構造物の破壊を伴う外耳道真珠腫症例の検討
    森田 真也; 中丸 裕爾; 福田 篤; 福田 諭
    Otology Japan, 26, 4, 495, 495, (一社)日本耳科学会, Sep. 2016
    Japanese
  • 中耳真珠腫の術前MRI拡散強調像の検討 T1強調像併用による診断精度向上の試み
    福田 篤; 森田 真也; 藤原 圭志; 中丸 裕爾; 福田 諭
    Otology Japan, 26, 4, 353, 353, (一社)日本耳科学会, Sep. 2016
    Japanese
  • The Outcomes of Surgery and Chemoradiotherapy for Temporal Bone Cancer
    Shinya Morita; Akihiro Homma; Yuji Nakamaru; Tomohiro Sakashita; Hiromitsu Hatakeyama; Satoshi Kano; Atsushi Fukuda; Satoshi Fukuda
    OTOLOGY & NEUROTOLOGY, 37, 8, 1174, 1182, Sep. 2016, [Peer-reviewed]
    English, Scientific journal
  • Comparison of hearing outcomes after treatment for early-stage external auditory canal cancer.
    Shinya Morita; Yuji Nakamaru; Akihiro Homma; Tomohiro Sakashita; Hiromitsu Hatakeyama; Masayori Masuya; Satoshi Fukuda
    Head & neck, 38 Suppl 1, E1110-6, Apr. 2016, [International Magazine]
    English, Scientific journal, BACKGROUND: The purpose of this study was to compare the hearing outcomes after surgery with reconstruction of the external auditory canal in combination with tympanoplasty, radiotherapy (RT) alone, and surgery followed by postoperative RT for T1 to 2N0M0 external auditory canal cancer. METHODS: We performed a retrospective, single-institution review of consecutive patients with early-stage external auditory canal cancer treated with surgery and/or RT between April 1997 and August 2013. Audiological data included the pretreatment hearing thresholds and those obtained at 12 months after the completion of therapy. RESULTS: When we compared the functional gains for air-conduction pure-tone average thresholds and mean air-bone gaps, those in the surgery group (n = 10) were significantly higher than those in the RT (n = 13) and surgery + RT (n = 5) groups. CONCLUSION: Adequate techniques for reconstruction of the external auditory canal in combination with tympanoplasty after complete surgical resection is useful for hearing preservation in addition to good survival outcomes. © 2015 Wiley Periodicals, Inc. Head Neck 38: E1110-E1116, 2016.
  • 当科における中耳真珠腫の術前MRI拡散強調像の検討
    福田 篤; 森田 真也; 中丸 裕爾; 福田 諭
    日本耳鼻咽喉科学会会報, 119, 4, 603, 603, (一社)日本耳鼻咽喉科学会, Apr. 2016
    Japanese
  • 隣接構造物の破壊を伴う外耳道真珠腫症例の検討
    森田 真也; 中丸 裕爾; 福田 篤; 福田 諭
    日本耳鼻咽喉科学会会報, 119, 4, 599, 599, (一社)日本耳鼻咽喉科学会, Apr. 2016
    Japanese
  • Comparison of hearing outcomes after treatment for early-stage external auditory canal cancer
    Shinya Morita; Yuji Nakamaru; Akihiro Homma; Tomohiro Sakashita; Hiromitsu Hatakeyama; Masayori Masuya; Satoshi Fukuda
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 38, E1110, E1116, Apr. 2016, [Peer-reviewed]
    English, Scientific journal
  • Otologic and Rhinologic Manifestations of Eosinophilic Granulomatosis with Polyangiitis.
    Yuji Nakamaru; Dai Takagi; Masanobu Suzuki; Aya Homma; Shinya Morita; Akihiro Homma; Satoshi Fukuda
    Audiology & neuro-otology, 21, 1, 45, 53, 2016, [International Magazine]
    English, Scientific journal, BACKGROUND: Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic autoimmune disease that manifests as asthma, recurrent sinusitis and peripheral eosinophilia. In this study, we investigated the clinical features of the ear and nasal manifestations of EGPA in comparison with those of granulomatosis with polyangiitis (GPA). MATERIALS AND METHODS: Twenty-one patients diagnosed with EGPA were studied. The frequency of otologic manifestations, the degree of hearing loss and the frequency of nasal symptoms were assessed. The onset of ear symptoms, sinusitis and asthma in patients with EGPA were also examined. RESULTS: Eleven patients (52.4%) with EGPA demonstrated otologic symptoms. The EGPA patients commonly presented mild-to-moderate mixed or sensorineural hearing loss. The pattern of hearing loss was mainly flat, and all but 1 patient achieved complete remission from their hearing impairments. Eighteen patients (85.7%) with EGPA demonstrated nasal symptoms. Patients with EGPA showed a significantly higher incidence of nasal polyps than did those with GPA. The median Lund and Mackey scoring system score was 13.7 for patients with EGPA, and ethmoid sinus shadows were more severe than those of the maxillary sinus. Most ear symptoms associated with EGPA were observed after definitive diagnosis, although sinusitis and asthma tended to manifest themselves before diagnosis. There were significant differences between the onset of ear symptoms and those of asthma and sinusitis. CONCLUSION: As over 80% of patients with EGPA had nasal symptoms and over half had ear symptoms, otolaryngologists should be aware of this disease. Recognition of the characteristic ear and nasal symptoms are thought to be particularly important to obtain an early diagnosis of EGPA.
  • The Short- and Long-Term Outcome of Intratympanic Steroid Therapy as a Salvage Treatment for Acute Low-Tone Sensorineural Hearing Loss without Episodes of Vertigo.
    Shinya Morita; Yuji Nakamaru; Keishi Fujiwara; Keiji Iizuka; Masayori Masuya; Akihiro Homma; Atsushi Fukuda; Satoshi Fukuda
    Audiology & neuro-otology, 21, 3, 132, 40, 2016, [International Magazine]
    English, Scientific journal, OBJECTIVES: To evaluate the hearing outcomes of intratympanic steroid (ITS) treatment for patients with acute low-tone sensorineural hearing loss (ALHL) after failure of initial therapy and to investigate the recurrence and progression to definite Ménière's disease (MD) during a long-term follow-up. METHODS: We retrospectively reviewed the medical records of 90 patients with refractory ALHL who were followed up for at least 1 year between January 2000 and April 2014. Patients who responded poorly to initial medical treatment received intratympanic dexamethasone injections (ITS group) or isosorbide administration for 4 weeks (diuretic group) as salvage treatment options according to their choice of management. The control group did not receive ITS or the diuretic, due to their refusal of both medical treatments. The hearing outcomes were evaluated 1 month, 1 year and 5 years after the completion of the second-line therapy, and the rates of recurrence and progression to MD were measured during a follow-up period of at least 1 year. RESULTS: Twenty-seven patients in the ITS group, 39 patients in the diuretic group and 24 patients in the control group were enrolled. Of these, 12 patients in the ITS group, 15 patients in the diuretic group and 12 patients in the control group were followed up for over 5 years. We found that the recovery rates and the audiometric functional values after 1 month and 1 year in the ITS group were significantly higher than those in the diuretic and control groups. However, there were no significant differences in the recovery rates or the audiometric functional values after 5 years, or in the rates of recurrence and progression to MD between the groups. CONCLUSIONS: Salvage ITS therapy can provide a relatively good short-term hearing outcome for ALHL patients who have persistent hearing loss despite conventional treatment. However, both recurrence and progression to MD after treatment were observed in some patients during the long-term follow-up.
  • Otologic and Rhinologic Manifestations of Eosinophilic Granulomatosis with Polyangiitis
    Yuji Nakamaru; Dai Takagi; Masanobu Suzuki; Aya Homma; Shinya Morita; Akihiro Homma; Satoshi Fukuda
    AUDIOLOGY AND NEURO-OTOLOGY, 21, 1, 45, 53, 2016, [Peer-reviewed]
    English, Scientific journal
  • The Short- and Long-Term Outcome of Intratympanic Steroid Therapy as a Salvage Treatment for Acute Low-Tone Sensorineural Hearing Loss without Episodes of Vertigo
    Shinya Morita; Yuji Nakamaru; Keishi Fujiwara; Keiji Iizuka; Masayori Masuya; Akihiro Homma; Atsushi Fukuda; Satoshi Fukuda
    AUDIOLOGY AND NEURO-OTOLOGY, 21, 3, 132, 140, 2016, [Peer-reviewed]
    English, Scientific journal
  • 急性感音難聴患者におけるムンプスIgM抗体陽性率の検討
    福田 篤; 森田 真也; 藤原 圭志; 中丸 裕爾; 福田 諭
    Otology Japan, 25, 4, 426, 426, (一社)日本耳科学会, Sep. 2015
    Japanese
  • 初期治療に抵抗を示した急性低音障害型感音難聴の検討
    森田 真也; 藤原 圭志; 中丸 裕爾; 福田 篤; 福田 諭
    Otology Japan, 25, 4, 425, 425, (一社)日本耳科学会, Sep. 2015
    Japanese
  • 耳鳴に対するエスシタロプラムの有効性
    桝谷 将偉; 中丸 裕爾; 森田 真也; 福田 諭
    耳鼻咽喉科・頭頸部外科, 86, 12, 1047, 1050, (株)医学書院, Nov. 2014
    Japanese, 耳鳴りに対する3ヵ月以上の内服治療で効果がなかった症例32例(男性23例、女性9例)を対象に、エスシタロプラム使用の有効性・安全性について検討した。対象のうち内服の継続が可能であった23例を評価対象とした。耳鳴りはTHIスコアで評価し、平均値は投与前41.3±25.9、8週目29.2±20.6、10週目29.1±20.4で、投与後8週目と10週目で有意な改善を認めた。8週目でスコアが低下したのは19例(82%)で、軽症(18〜36点)以下で11例中9例、中等症(38〜56点)で5例中3例、重症(59〜100点)で5例中5例、最重症で2例中2例であった。うち有意改善は9例(39%)で、軽症以下で2例、中等症で3例、重症で3例、最重症で1例であった。有害事象は参加症例32例中14例で認め、うち9例は内服中断後に症状は速やかに消失した。以上より、エスシタロプラムはTHIスコア中等症以上の耳鳴りに有効であることが示唆された。
  • 早期外耳道癌症例における治療前後の聴力に関する検討
    森田 真也; 中丸 裕爾; 桝谷 将偉; 福田 諭
    Otology Japan, 24, 4, 623, 623, (一社)日本耳科学会, Sep. 2014
    Japanese
  • 経口ステロイド内服と鼓膜チューブ留置により治療した中耳コレステリン肉芽腫の2例
    桝谷 将偉; 中丸 裕爾; 森田 真也; 福田 諭
    Otology Japan, 24, 4, 381, 381, (一社)日本耳科学会, Sep. 2014
    Japanese
  • 早期外耳道癌症例に対する治療前後の聴力に関する検討
    森田 真也; 中丸 裕爾; 本間 明宏; 坂下 智博; 桝谷 将偉; 福田 諭
    日本耳鼻咽喉科学会会報, 117, 4, 565, 565, (一社)日本耳鼻咽喉科学会, Apr. 2014
    Japanese
  • Characteristics and prognosis of hearing loss associated with Vogt-Koyanagi-Harada disease.
    Shinya Morita; Yuji Nakamaru; Nobuyuki Obara; Masayori Masuya; Satoshi Fukuda
    Audiology & neuro-otology, 19, 1, 49, 56, 2014, [International Magazine]
    English, Scientific journal, OBJECTIVE: To clarify the characteristics and prognosis of hearing loss associated with Vogt-Koyanagi-Harada (VKH) disease. METHODS: We retrospectively examined 85 patients diagnosed with VKH disease between January 1996 and December 2012. The control group included age- and gender-matched individuals without definitive ear disease. The patients with VKH disease were treated with high-dose systemic corticosteroids, which were tapered off gradually over a period of 6 months or more by the treating ophthalmologists according to the severity of the ocular inflammation. The features of hearing loss were analyzed based on pure tone audiometric data obtained at the initial presentation according to diagnostic criteria based on the ISO 7029 standard. The efficacy of corticosteroid therapy was evaluated by audiometry at the initial presentation and during therapy for 3-6 months. RESULTS: In patients with VKH disease, the rate of hearing loss detected by audiometry was significantly higher than that of either subjective hearing loss (p < 0.001) or tinnitus (p < 0.001). Bilateral symmetrical hearing loss was the most common type of auditory disturbance associated with VKH disease. The degree of hearing loss was generally low, with no patients showing profound hearing loss. Hearing thresholds were significantly elevated at high frequencies compared with those at low-to-mid frequencies (p < 0.001). Hearing thresholds at all frequencies after high-dose corticosteroid therapy were significantly better than those at initial presentation (p < 0.001), and the rate of patients who returned to within normal-range pure tone thresholds at all frequencies was 74.8%. CONCLUSIONS: As auditory manifestations cannot be detected through history taking alone, audiometry should be performed to evaluate hearing loss associated with VKH disease. Early administration of high-dose systemic corticosteroids is effective for treating the auditory manifestations, which generally show a relatively good short-term prognosis.
  • Hearing preservation after lateral temporal bone resection for early-stage external auditory canal carcinoma.
    Shinya Morita; Yuji Nakamaru; Akihiro Homma; Tomohiro Sakashita; Masayori Masuya; Satoshi Fukuda
    Audiology & neuro-otology, 19, 6, 351, 7, 2014, [International Magazine]
    English, Scientific journal, OBJECTIVE: To evaluate postoperative hearing outcomes after lateral temporal bone resection (LTBR) with reconstruction of the external auditory canal (EAC) and conductive function for early-stage EAC carcinoma. METHODS: We retrospectively examined patients diagnosed with early-stage EAC carcinoma treated with surgery alone between January 2006 and December 2012. Patients who had postoperative adjuvant chemotherapy and/or radiotherapy were excluded. Patients receiving LTBR in combination with tympanoplasty were divided into two groups based on the reconstruction of the EAC with and without (w/o) split-thickness skin grafts (STSGs). Audiological data included the preoperative hearing thresholds and the most recent postoperative hearing thresholds obtained at least 12 months after surgery. The hearing outcome was evaluated based on pure-tone audiograms using the Committee on Hearing and Equilibrium guidelines of the American Academy of Otolaryngology-Head and Neck Surgery for the evaluation of the results of treatment of conductive hearing loss. The postoperative quality of life (QOL) for patients was evaluated using the Glasgow Benefit Inventory (GBI). RESULTS: All patients (n = 15) achieved disease-free survival without significant morbidity or mortality. When we compared the mean air-bone gaps after surgery, those in the STSG group (n = 8) were found to be significantly lower than those in the w/o STSG group (n = 7; p < 0.001). The success rate for postoperative hearing was 75.0% in the STSG group, which was significantly higher than that in the w/o STSG group (p = 0.014). All patients in the w/o STSG group showed stenosis and closure of the EAC at fewer than 10 months after surgery. In contrast, all patients in the STSG group showed preserved conformation of the new EAC for more than 12 months after surgery. When we compared the mean GBI score between the two groups of patients, the overall and general health scores in the STSG group were found to be significantly higher than those in the w/o STSG group (p = 0.021, p = 0.001). CONCLUSIONS: Reconstruction of the EAC using a rolled-up STSG technique in combination with tympanoplasty after LTBR is useful for hearing preservation and the observation of locoregional lesions after surgery, resulting in improved QOL for patients.
  • Characteristics and Prognosis of Hearing Loss Associated with Vogt-Koyanagi-Harada Disease
    Shinya Morita; Yuji Nakamaru; Nobuyuki Obara; Masayori Masuya; Satoshi Fukuda
    AUDIOLOGY AND NEURO-OTOLOGY, 19, 1, 49, 56, 2014, [Peer-reviewed]
    English, Scientific journal
  • Hearing Preservation after Lateral Temporal Bone Resection for Early-Stage External Auditory Canal Carcinoma
    Shinya Morita; Yuji Nakamaru; Akihiro Homma; Tomohiro Sakashita; Masayori Masuya; Satoshi Fukuda
    AUDIOLOGY AND NEURO-OTOLOGY, 19, 6, 351, 357, 2014, [Peer-reviewed]
    English, Scientific journal
  • 耳鳴に対するエスシタロプラムの有効性に関する検討
    桝谷 将偉; 中丸 裕爾; 森田 真也; 福田 諭
    Otology Japan, 23, 4, 774, 774, (一社)日本耳科学会, Oct. 2013
    Japanese
  • 外側側頭骨切除術に一期的鼓室形成術を施行した早期外耳道癌症例の検討
    中丸 裕爾; 森田 真也; 桝谷 将偉; 福田 諭
    Otology Japan, 23, 4, 669, 669, (一社)日本耳科学会, Oct. 2013
    Japanese
  • Vogt-小柳-原田病における聴力像の特徴および聴力予後の検討
    森田 真也; 中丸 裕爾; 小原 修幸; 桝谷 将偉; 福田 諭
    Otology Japan, 23, 4, 513, 513, (一社)日本耳科学会, Oct. 2013
    Japanese
  • 早期外耳道癌に対して外側側頭骨切除術に一期的鼓室形成術を施行した4症例
    森田 真也; 中丸 裕爾; 福田 諭
    Otology Japan, 22, 4, 579, 579, (一社)日本耳科学会, Sep. 2012
    Japanese
  • False-negative diffusion-weighted MRI in acute cerebellar stroke.
    Shinya Morita; Masanobu Suzuki; Keiji Iizuka
    Auris, nasus, larynx, 38, 5, 577, 82, Oct. 2011, [International Magazine]
    English, Scientific journal, OBJECTIVE: To heighten physician awareness of false-negative diffusion-weighted (DW) magnetic-resonance imaging findings in patients with acute cerebellar infarction and the importance of periodically observing nystagmus after symptom onset. METHODS: Between April 2007 and March 2010, we retrospectively reviewed the medical records of eight patients who had all complained of severe isolated vertigo or dizziness, and had visited an emergency department within 2-6h of its onset. Intracranial findings on initial magnetic resonance imaging (MRI) were normal. All patients had consulted our department for peripheral vestibular disorders. We periodically observed spontaneous and positional nystagmus 6-24h after symptom onset. RESULTS: In three of the patients, the direction and/or type of nystagmus changed periodically. In four of the patients, severe vertigo, nausea, and vomiting persisted after the nystagmus had been resolved. A repeat MR examination was performed 24h after symptom onset because of the atypical pattern of nystagmus for benign peripheral vestibular disorders, at which point cerebellar infarction was detected. CONCLUSIONS: Physicians who examine patients with acute severe isolated vertigo or dizziness should consider the possibility of false-negative DW MRI findings in case of hyperacute ischemic stroke. It is important to observe the nystagmus periodically after onset. The MR examination should be repeated more than 24h after symptom onset in patients with an atypical pattern of nystagmus for benign peripheral vestibular disorders.
  • False-negative diffusion-weighted MRI in acute cerebellar stroke
    Shinya Morita; Masanobu Suzuki; Keiji Iizuka
    AURIS NASUS LARYNX, 38, 5, 577, 582, Oct. 2011, [Peer-reviewed]
    English, Scientific journal
  • A Case of Immunoglobulin 4-Related Disease With Bilateral Mass-Forming Lesions in the Nasolacrimal Ducts
    Masanobu Suzuki; Takatsugu Mizumachi; Shinya Morita; Kanako Kubota; Keiji Iizuka
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 17, 4, 207, 210, Jun. 2011, [Peer-reviewed]
    English, Scientific journal
  • 垂直上眼瞼向き眼振が改善したWernicke脳症疑いの1例
    鈴木 正宣; 宮腰 浩世; 森田 真也; 飯塚 桂司
    市立釧路総合病院医学雑誌, 23, 1, 93, 96, 市立釧路総合病院, Mar. 2011
    Japanese
  • IgG4関連疾患が疑われた症例の検討
    鈴木 正宣; 宮腰 浩世; 森田 真也; 飯塚 桂司
    市立釧路総合病院医学雑誌, 23, 1, 3, 8, 市立釧路総合病院, Mar. 2011
    Japanese
  • Paranasal sinus mucoceles with visual disturbance.
    Shinya Morita; Kenji Mizoguchi; Keiji Iizuka
    Auris, nasus, larynx, 37, 6, 708, 12, Dec. 2010, [International Magazine]
    English, Scientific journal, OBJECTIVE: Paranasal sinus mucoceles may cause visual disturbance in patients because of their close proximity to the orbit. We aimed to investigate visual prognosis to determine whether it is influenced by the interval before surgery and the severity of visual disturbance, and to heighten the physician's awareness of the occurrence of this disease. METHODS: We retrospectively reviewed eight surgically treated patients with paranasal sinus mucoceles accompanied by visual disturbances between March 2005 and January 2009, and examined the visual acuity outcome of the patients. RESULTS: Four patients with a mild visual acuity loss showed improvement after surgical drainage within 1 month after onset. Two patients with visual disturbances persisting for more than 1 year did not show postoperative improvements. Although two patient's preoperative visual acuity loss was worse than the ability to count fingers, they showed a remarkable improvement after surgery. CONCLUSIONS: These results show the importance of diagnosing and treating paranasal sinus mucoceles with visual disturbance as soon as possible. In addition, the improvement of visual acuity can be expected if surgery is performed within 1 month after onset, and the patient's preoperative visual acuity loss is mild. However, if patients with severe visual acuity loss consult otolaryngologists at a later date, surgery may still be considered worthwhile.
  • Paranasal sinus mucoceles with visual disturbance
    Shinya Morita; Kenji Mizoguchi; Keiji Iizuka
    AURIS NASUS LARYNX, 37, 6, 708, 712, Dec. 2010, [Peer-reviewed]
    English, Scientific journal
  • The accuracy of (18)[F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography, ultrasonography, and enhanced computed tomography alone in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma.
    Shinya Morita; Kenji Mizoguchi; Masanobu Suzuki; Keiji Iizuka
    World journal of surgery, 34, 11, 2564, 9, Nov. 2010, [International Magazine]
    English, Scientific journal, BACKGROUND: The aim of this study was to evaluate the accuracy of [(18)F]-fluoro-2-deoxy-D: -glucose-positron emission tomography/computed tomography, ultrasonography, and enhanced computed tomography alone in the preoperative diagnosis of lymph node metastasis in patients with papillary thyroid carcinoma. METHODS: In a prospective study performed between January 2007 and December 2009, 74 patients with a diagnosis of papillary thyroid carcinoma confirmed by fine-needle aspiration biopsy were referred to our institution for surgery. Preoperative assessment of metastasis in the central and lateral cervical lymph nodes was done using [(18)F]-fluoro-2-deoxy-D: -glucose-positron emission tomography/computed tomography, ultrasonography, and enhanced computed tomography. The results for each level of cervical node assessed using these methods were correlated with the pathology reports after surgery. We determined the sensitivity, specificity, positive and negative predictive values, and diagnostic accuracy of the three methods for all levels of cervical lymph node. RESULTS: There were no significant differences in the diagnostic results obtained by [(18)F]-fluoro-2-deoxy-D: -glucose-positron emission tomography/computed tomography and enhanced computed tomography. However, ultrasonography images gave significantly better results than either [(18)F]-fluoro-2-deoxy-D: -glucose-positron emission tomography/computed tomography or enhanced computed tomography alone in identifying metastases on the basis of the level of cervical lymph node. In addition, the overall diagnostic accuracy tended to be higher for the lateral compartment than for the central compartment. CONCLUSIONS: Preoperative assessment by ultrasonography of metastases in the central and lateral cervical lymph nodes might be the best methodology for determining the extent of surgical resection required to remove metastatic lymph nodes adequately in patients with papillary thyroid carcinoma.
  • A case of idiopathic lymph leakage in the neck.
    Masanobu Suzuki; Shinya Morita; Keiji Iizuka
    Auris, nasus, larynx, 37, 4, 535, 7, Aug. 2010, [International Magazine]
    English, Scientific journal, A 48-year-old female patient was seen in our institution complaining of sudden onset of swelling and tenderness in the left side of her neck. Computed tomography and magnetic resonance imaging revealed abundant effusions in this area. Since these narrowed the patient's airway, we performed incisional drainage and intra-operatively we observed a transparent, colorless lymph fluid that oozed from the operative field, which was mainly a fatty layer at the supraclavicular area. Dilated lymphatic ducts were seen along the carotid artery and internal jugular vein, but damaged lymphatic ducts and obvious causative disease structures like tumorous lesions were not seen. Idiopathic lymph leakage was diagnosed due to the serous discharge from the left side of the neck and no apparent causative disease. The patient was successfully treated with incisional drainage and dietary restriction. Lymph leakage in the neck is more common after trauma or surgery. To our knowledge, no similar cases have ever been reported.
  • A case of idiopathic lymph leakage in the neck
    Masanobu Suzuki; Shinya Morita; Keiji Iizuka
    AURIS NASUS LARYNX, 37, 4, 535, 537, Aug. 2010, [Peer-reviewed]
    English, Scientific journal
  • Non-organic hearing loss in childhood.
    Shinya Morita; Masanobu Suzuki; Keiji Iizuka
    International journal of pediatric otorhinolaryngology, 74, 5, 441, 6, May 2010, [International Magazine]
    English, Scientific journal, OBJECTIVE: The present study aimed to investigate the etiology, symptoms, diagnosis and prognosis of pediatric patients with non-organic hearing loss (NOHL), and to heighten awareness of this disorder among physicians. METHODS: Between January 2000 and July 2009, we retrospectively reviewed the medical records of 47 pediatric patients (aged 6-18 years of age) diagnosed with NOHL. The diagnosis was made when there were audiometric discrepancies between the subjective and objective hearing thresholds of the patient in the absence of any organic disease. RESULTS: Eighteen patients presented with unilateral hearing loss, and 29 showed bilateral hearing loss. Five patients received steroid treatment before the correct diagnosis was made, and six had secretory otitis media and underwent a tympanostomy tube placement. CONCLUSION: If physicians are unaware of the possibility of NOHL; they may misdiagnose children with idiopathic sudden sensorineural hearing loss and administer high-dose steroid treatments or exploratory tympanotomies. Otoacoustic emissions are abolished when NOHL patients have secretory otitis media. In these cases, after tympanostomy tube placement, they should undergo objective electrophysiologic examinations to reevaluate NOHL.
  • Non-organic hearing loss in childhood
    Shinya Morita; Masanobu Suzuki; Keiji Iizuka
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 74, 5, 441, 446, May 2010, [Peer-reviewed]
    English
  • 胸骨柄当該皮下に生じた類皮嚢胞の1例
    鈴木 正宣; 森田 真也; 飯塚 桂司
    市立釧路総合病院医学雑誌, 22, 1, 89, 92, 市立釧路総合病院, Mar. 2010
    Japanese
  • 後天性後鼻腔閉鎖症の1例
    鈴木 正宣; 森田 真也; 飯塚 桂司
    市立釧路総合病院医学雑誌, 22, 1, 83, 87, 市立釧路総合病院, Mar. 2010
    Japanese
  • 気管支喘息と誤認された気管支異物の1例
    森田 真也; 鈴木 正宣; 飯塚 桂司
    市立釧路総合病院医学雑誌, 22, 1, 77, 81, 市立釧路総合病院, Mar. 2010
    Japanese
  • 上顎癌に対する超選択的動注療法
    森田 真也; 鈴木 正宣; 稲村 茂; 今泉 俊雄; 飯塚 桂司
    市立釧路総合病院医学雑誌, 22, 1, 11, 17, 市立釧路総合病院, Mar. 2010
    Japanese
  • [Prevention of wound complications after salvage total laryngectomy following chemoradiotherapy with a pectoralis major muscle interposition flap].
    Yasushi Furuta; Michiya Matsumura; Fumio Ohtani; Masanobu Suzuki; Hiroki Satoh; Shinya Morita; Akihiro Homma; Nobuhiko Oridate; Satoshi Fukuda
    Nihon Jibiinkoka Gakkai kaiho, 113, 1, 9, 14, Jan. 2010, [Domestic magazines]
    Japanese, Scientific journal, There is an increased risk of wound complications in patients undergoing salvage laryngectomy following chemoradiotherapy. To reduce the rate of wound complications after a salvage total laryngectomy, a fresh tissue reinforcement of the pharyngeal suture line (pharyngeal interposition graft) has been reported to be useful. In the present study, wound complications after a salvage total laryngectomy with a pectoralis major muscle flap as a pharyngeal interposition graft were analyzed. Four patients with recurrent laryngeal cancer (three with supraglottic, and one with glottic cancer) after chemoradiotherapy underwent salvage total laryngectomy using a pectoralis major muscle interposition flap. Minor wound complications were observed in three of the four patients, with an infection around the tracheostoma, a minor subcutaneous abscess, and a superficial skin necrosis in one patient each. These complications were managed with local wound care. No patients had major wound complications such as pharyngocutaneous fistulas. There were no necroses or wound complications of the pectoralis major muscle flap. This study has suggested that the pectoralis major muscle flap as a pharyngeal interposition graft is safe and useful for prevention of wound complications in salvage total laryngectomy following chemoradiotherapy.
  • A comparison of the short-term outcome in patients with acute low-tone sensorineural hearing loss.
    Shinya Morita; Masanobu Suzuki; Keiji Iizuka
    ORL; journal for oto-rhino-laryngology and its related specialties, 72, 6, 295, 9, 2010, [International Magazine]
    English, Scientific journal, PURPOSE OF THE STUDY: We aimed to compare the short-term outcome of patients with acute low-tone sensorineural hearing loss (ALHL) treated with steroid alone, diuretics alone or combination treatment. PROCEDURES: Between April 2000 and March 2009, we retrospectively reviewed the medical records of 156 patients with a diagnosis of ALHL. All patients were followed up until improvement or for 8 weeks from the initial examination. Patients were treated with steroid alone (n = 49), diuretics alone (n = 40), combination treatment (n = 46) or they received neither steroid nor diuretics (n = 21). RESULTS: The steroid-diuretic combination therapy for ALHL showed significantly better results than the steroid or diuretic treatments alone (p < 0.05). There were no clinically significant differences in the outcome between the steroid- and diuretic-alone treatments. CONCLUSION AND MESSAGE: The etiology of ALHL is described as both an endolymphatic hydrops and an autoimmunological mechanism so that, as expected, the steroid-diuretic combination therapy was more effective than the steroid or diuretic treatments alone.
  • Prevention of wound complications after salvage total laryngectomy following chemoradiotherapy with a pectoralis major muscle interposition flap
    Yasushi Furuta; Michiya Matsumura; Fumio Ohtani; Masanobu Suzuki; Hiroki Satoh; Shinya Morita; Akihiro Homma; Nobuhiko Oridate; Satoshi Fukuda
    Journal of Otolaryngology of Japan, 113, 1, 9, 14, Oto-Rhino-Laryngological Society of Japan Inc., 2010
    Japanese, Scientific journal
  • 反復性鼻出血に対する内視鏡下蝶口蓋動脈結紮術施行例の検討
    鈴木 正宣; 大谷 文雄; 松村 道哉; 蠣崎 文彦; 森田 真也; 佐藤 宏紀; 中丸 裕爾; 古田 康
    耳鼻咽喉科・頭頸部外科, 82, 1, 67, 72, (株)医学書院, Jan. 2010
    Japanese, 反復性鼻出血に対し内視鏡下蝶口蓋動脈結紮術を施行した14例15側(男11例・女3例・42〜76歳)について報告した。適応は、保存的療法で止血できず、蝶口蓋動脈の支配領域からの出血が疑われる症例とした。鼻出血の危険因子として、高血圧合併8例、5例に抗凝固薬使用を認めた。術前全例にガーゼタンポンがなされ、うち9例はバルーンタンポンも施行した。術前の輸血は2例に要した。手術時間は平均80分で、粘膜下下甲介切除術を7例に、鼻中隔矯正術を4例に併施した。出血量はほとんどが少量であったが、4例では100〜400mlと多かった。術後のガーゼ留置期間は平均1.6日間で、ガーゼ抜去時の出血が3例でみられたが、動脈性ではなくガーゼで止血できた。血小板機能異常を合併した1例のみ術後も出血が続き、バイポーラー焼灼術、アルゴンプラズマレーザーによる鼻腔粘膜焼灼術を要した。手術から退院までの平均日数は4.9日で、重篤な合併症はなかった。
  • Prevention of wound complications after salvage total laryngectomy following chemoradiotherapy with a pectoralis major muscle interposition flap
    Yasushi Furuta; Michiya Matsumura; Fumio Ohtani; Masanobu Suzuki; Hiroki Satoh; Shinya Morita; Akihiro Homma; Nobuhiko Oridate; Satoshi Fukuda
    Journal of Otolaryngology of Japan, 113, 1, 9, 14, Oto-Rhino-Laryngological Society of Japan Inc., 2010, [Peer-reviewed]
    Japanese, Scientific journal
  • A Comparison of the Short-Term Outcome in Patients with Acute Low-Tone Sensorineural Hearing Loss
    Shinya Morita; Masanobu Suzuki; Keiji Iizuka
    ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 72, 6, 295, 299, 2010, [Peer-reviewed]
    English, Scientific journal
  • 過去5年間の当科における異物症例の検討
    溝口 兼司; 森田 真也; 山本 潤; 飯塚 桂司
    市立釧路総合病院医学雑誌, 21, 1, 79, 85, 市立釧路総合病院, Mar. 2009
    Japanese
  • Bell麻痺症例に対する治療の検討
    森田 真也; 溝口 兼司; 飯塚 桂司
    市立釧路総合病院医学雑誌, 21, 1, 73, 78, 市立釧路総合病院, Mar. 2009
    Japanese
  • 急性低音障害型難聴に対する治療の検討
    森田 真也; 溝口 兼司; 飯塚 桂司
    市立釧路総合病院医学雑誌, 21, 1, 65, 68, 市立釧路総合病院, Mar. 2009
    Japanese
  • 分化型甲状腺癌における術前診断としてのFDG-PETの評価
    溝口 兼司; 森田 真也; 飯塚 桂司
    市立釧路総合病院医学雑誌, 21, 1, 57, 63, 市立釧路総合病院, Mar. 2009
    Japanese
  • 当院救急外来におけるめまい患者についての検討
    佐藤 宏紀; 古田 康; 松村 道哉; 森田 真也; 大西 新介; 高橋 功; 高田 訓; 堂坂 善弘
    手稲渓仁会病院医学雑誌, 9, 1, 15, 20, (医)渓仁会手稲渓仁会病院, Dec. 2008
    Japanese, めまい・ふらつきを主訴に救急外来を受診した214例(男84例・女130例・平均63歳)について報告した。めまいの性状は回転性96例、失神性・その他69例、浮動性49例であった。随伴症状は自律神経症状87例、中枢神経症状24例、頭痛14例、蝸牛症状10例などで、随伴症状なしは49例であった。眼振を認めたのは94例で、中枢性めまいを疑うものは22例(側方注視16例・垂直性6例)であったが、そのうち中枢性めまいと診断されたのは2例のみであった。初診時診断は末梢性めまい118例、中枢性めまい12例、自律神経障害11例、過換気症候群4例、その他のめまいが69例であった。救急外来受診後に他科を受診したのは169例で、耳鼻咽喉科93例、内科34例、脳神経外科31例であった。画像検査で責任病変を発見できた中枢性めまい患者は11例で、脳出血3例、脳梗塞8例であった。このうち2例は初診時明らかな神経学的所見がなく、末梢性めまいと診断されていた。
  • 頭蓋外内頸動脈瘤の1例
    森田 真也; 高田 訓; 松村 道哉; 佐藤 宏紀; 古田 康
    耳鼻咽喉科・頭頸部外科, 80, 9, 637, 639, (株)医学書院, Aug. 2008
    Japanese, 83歳男。3日前より咽頭痛が出現し、近医で右扁桃周囲の腫脹を指摘され、膿瘍形成を疑い穿刺したところ動脈性出血を来たし当科紹介受診した。入院時所見で中咽頭右側壁が著明に膨隆しており、拍動を観察できた。造影CTでは内部の一部に高吸収域を伴い、周囲被膜が増強される腫瘤を認め、右内頸動脈は後外方に偏位し、咽頭腔も圧排されていた。3D-CTでは右内頸動脈から前方へ嚢状に拡張した血管陰影を認め、血管造影で嚢状動脈瘤と確認できた。絶飲食で入院2日目に咽頭痛は消失し、粥食開始後も出血は認めなかった。神経症状を認めないこと、高齢であること、慢性閉塞性肺疾患や特発性血小板減少性紫斑病などの合併症の存在、腫瘤の部位から外科的手術アプローチが困難であること、血管内治療による合併症の可能性などを考慮し、積極的治療は行わず経過観察とした。10ヵ月経過現在、中枢神経症状、破裂による出血、腫瘤増大による下位脳神経圧迫症状は認めていない。
  • 【頸部の腫れをどう扱うか】 頸部の腫れへのアプローチ
    森田 真也; 古田 康
    ENTONI, 89, 1, 7, (株)全日本病院出版会, Jun. 2008
    Japanese
  • [Preoperative embolization and postoperative complications of carotid body tumors].
    Shinya Morita; Yasushi Furuta; Akihiro Honma; Fumiyuki Suzuki; Kaori Fujita; Satoshi Fukuda
    Nihon Jibiinkoka Gakkai kaiho, 111, 3, 96, 101, Mar. 2008, [Domestic magazines]
    Japanese, Scientific journal, Carotid body tumors are uncommon neoplasms that arise at the bifurcation of the common carotid artery. Surgical resection is generally recommended, but entails an inherent risk of cranial nerves injury and excessive blood loss. Preoperative embolization has been reported to decrease blood loss and shorten resection time. In this study, we analyzed the benefits of preoperative embolization and the postoperative complications when preoperative embolization was performed. Six patients with seven tumors were treated between 1990 and 2005. Each patient's preoperative evaluation included CT, MRI, US, and angiography, and preoperative embolization was performed in four patients with five tumors. Blood loss, in the patients who underwent preoperative embolization, ranged from 20 ml to 900 ml (mean: 291ml), and operation time ranged from 4 hours 34 minutes to 6 hours 40 minutes (mean: 4 hours 55 minutes). In the group that did not undergo preoperative embolization, blood loss ranged from 642 ml to 1390 ml (mean: 1016 ml), and operation time ranged from 9 hours 48 minutes to 10 hours 45 minutes (mean: 10 hours 17 minutes). Five patients had postoperative cranial nerve dysfunction, and it involved cranial nerve IX in one patient (14.3%), cranial nerve X in two patients (28.5%), and cranial nerve XII in five patients (71.4%). Resection of bilateral carotid body tumors in one patient resulted in baroreflex failure syndrome. In conclusion, preoperative embolization tends to decrease blood loss and shorten operation time, resulting in lower postoperative neurologic morbidity.
  • Preoperative embolization and postoperative complication of carotid body tumors
    Shinya Morita; Yasushi Furuta; Akihiro Honma; Fumiyuki Suzuki; Kaori Fujita; Satoshi Fukuda
    Journal of Otolaryngology of Japan, 111, 3, 96, 101, Oto-Rhino-Laryngological Society of Japan Inc., 2008, [Peer-reviewed]
    Japanese, Scientific journal
■ Other Activities and Achievements
■ Syllabus
  • 基本医学研究, 2024年, 修士課程, 医学院
  • 基本医学総論, 2024年, 修士課程, 医学院
  • 応用社会行動科学, 2024年, 修士課程, 医学院
  • 応用社会行動科学, 2024年, 修士課程, 医学院
  • 応用社会行動科学, 2024年, 修士課程, 医学院
  • 医学総論, 2024年, 博士後期課程, 医学院
  • 基盤医学研究, 2024年, 博士後期課程, 医学院
  • 臨床医学研究, 2024年, 博士後期課程, 医学院
  • 臨床生理学Ⅲ, 2024年, 学士課程, 医学部
  • 耳鼻咽喉科学, 2024年, 学士課程, 医学部
■ Research Themes
  • 難治性中耳炎におけるDNase耐性細胞外トラップ形成機序の解明と治療標的の探索
    科学研究費助成事業
    01 Apr. 2026 - 31 Mar. 2030
    森田 真也
    日本学術振興会, 基盤研究(C), 北海道大学, 26K12381
  • The formation and degradation of neutrophil and eosinophil extracellular traps in otitis media
    Grants-in-Aid for Scientific Research
    01 Apr. 2023 - 31 Mar. 2026
    森田 真也
    近年では、好中球や好酸球から放出される細胞外トラップ(ETs)形成がANCA関連血管炎性中耳炎や好酸球性中耳炎などの難治性中耳炎の発症に関与していることが示唆されている。本研究の目的は、難治性中耳炎患者の臨床検体やマウスを用いて、ETs形成-分解経路と病態に対する関与を解明し、診断や疾患活動性を評価する新規のバイオマーカーおよび治療ターゲットを探求することである。
    2023年度の研究では、「被験者から採取した臨床検体を用いて耳鼻咽喉科領域での好中球および好酸球ETsの存在を確認する」、「被験者から採取した臨床検体を用いて好中球および好酸球ETs分解能を評価する」ことを行った。
    まず、蛍光顕微鏡を用いた画像解析で中耳貯留液を観察したところ、難治性中耳炎患者から採取された中耳貯留液ではETsの形成が確認できた。次に、cell-free DNA、シトルリン化ヒストンDNA複合体などのETs代謝産物をELISA法で定量的な測定を行ったところ、難治性中耳炎患者から採取された中耳貯留液では、これらのETs代謝産物の発現レベル値が高値を示した。さらに、ETsを分解するDNaseI活性を測定したところ、難治性中耳炎患者においてはDNaseI活性が低下していた。ETs代謝産物の発現レベル値とDNaseI活性は負の相関関係を示していることから、ETsの過剰形成と分解能低下が難治性中耳炎の発症と重症度に関与していると示唆された。
    2024年度以降は、「DNase阻害剤またはDNaseノックアウトマウスを用いてETsが分解されることなくどこでどのような障害を与えるのか」、「ETs形成阻害または分解活性によって難治性中耳炎の発症が抑制できるのか」を検証する。最終的には、臨床的側面との関連性を明らかにし、診断や疾患活動性を評価するバイオマーカーおよび治療ターゲットとして有用性があるかを検証する。
    Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C), Hokkaido University, 23K08953
  • The analysis for clinical utility and role of the myeloperoxidase-deoxyribonucleic acid complex in otitis media with antineutrophil cytoplasmic antibody-associated vasculitis
    Grants-in-Aid for Scientific Research
    01 Apr. 2020 - 31 Mar. 2023
    森田 真也
    昨年度は、被験者から採取した臨床検体(血液および中耳貯留液)を用いて、NETosisの際に放出されるMPO-DNA複合体、cell-free DNA、シトルリン化ヒストン-DNA複合体を好中球細胞外トラップ(NETs)と定義して測定を行った。しかし、NETs代謝産物を測定しているため正確にはNETosisと、その結果発生するNETsを直接的に評価したわけではない。そこで今年度は、蛍光顕微鏡を用いた画像解析で中耳貯留液においてNETosisが発生しているか評価した。
    ANCA関連血管炎性中耳炎から採取された中耳貯留液では、蛍光顕微鏡を用いた画像解析でNETosisの発生が確認できた。昨年度にELISA法で解析したMPO-DNA複合体、cell-free DNA、シトルリン化ヒストン-DNA複合体のレベル値との整合性があると思われた。一方、滲出性中耳炎から採取された中耳貯留液ではNETosisの発生は確認できなかった。
    近年では、NETsがANCA関連血管炎性中耳炎の病態に重要な役割を果たすことが示唆されている。NETsは、NETosisと呼ばれる特殊な細胞死を起こした好中球から放出される細胞外DNAと約20種類の細胞質内酵素から構成される。現在までに報告されているNETosisの評価方法は、これらの細胞外DNAと酵素に着目している。しかし、標準的な評価方法は確立されておらず、様々な方法が存在する。昨年度と今年度の研究結果から、中耳炎の病態を考慮に入れて適切なNETosis評価方法を選択する必要があると考えられた。
    Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C), Hokkaido University, 20K09744
  • The management for external auditory canal squamous cell carcinoma based on genomic and proteomic analysis
    Grants-in-Aid for Scientific Research
    01 Apr. 2017 - 31 Mar. 2022
    MORITA SHINYA
    This study analyzed genetic mutations based on targeted next-generation sequencing in tissue samples to explore somatic gene mutations associated with the clinicopathological features in patients with external auditory canal squamous cell carcinoma. Gene alterations were most frequently observed in TP53 (59.1%), followed by CREBBP (9.1%). However, except for TP53, this analysis did not identify mutations in major cancer-related gene, such as NOTCH1, FAT1, CDKN2A and PIK3CA. TP53 mutations showed significant correlation with T classification (p=0.027). Multivariable analysis using the Cox proportional hazards model demonstrated that TP53 mutations were independent predictors of overall survival rates for EACSCC patients (p=0.007).
    Japan Society for the Promotion of Science, Grant-in-Aid for Young Scientists (B), Hokkaido University, 17K16883